Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID1019 | LAEGGGVR | Fibrinopeptide A | Serum | 758.45 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Downregulated in cancer vs normal with Ratio of median intensity (patients/Controls) = 0.66, 0.95 and 0.65 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1020 | FLAEGGGVR | Fibrinopeptide A | Serum | 905.5 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "For bladder (Lower) and for breast (Higher) Differential ion intensity in cancer compare to normal with Ratio of median intensity (patients/Controls) = 0.97, 0.73 and 1.48 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1021 | DFLAEGGGVR | Fibrinopeptide A | Serum | 1020.47 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Downregulated in cancer vs normal with Ratio of median intensity (patients/Controls) = 0.28, 0.28 and 0.47 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1022 | GDFLAEGGGVR | Fibrinopeptide A | Serum | 1077.53 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Downregulated in cancer vs normal with Ratio of median intensity (patients/Controls) = 0.54, 0.5 and 0.97 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1023 | EGDFLAEGGGVR | Fibrinopeptide A | Serum | 1206.57 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Downregulated in cancer vs normal with Ratio of median intensity (patients/Controls) = 0.5, 0.44 and 0.69 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1024 | GEGDFLAEGGGVR | Fibrinopeptide A | Serum | 1263.6 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Downregulated in cancer vs normal with Ratio of median intensity (patients/Controls) = 0.2, 0.24 and 0.23 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1025 | SGEGDFLAEGGGVR | Fibrinopeptide A | Serum | 1350.64 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Downregulated in cancer vs normal with Ratio of median intensity (patients/Controls) = 0.47, 0.46 and 0.35 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1026 | DSGEGDFLAEGGGVR | Fibrinopeptide A | Serum | 1465.65 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Downregulated in cancer vs normal with Ratio of median intensity (patients/Controls) = 0.66, 0.55 and 0.8 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1027 | ADSGEGDFLAEGGGVR | Fibrinopeptide A | Serum | 1536.68 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Downregulated in cancer vs normal with Ratio of median intensity (patients/Controls) = 0.58, 0 and 0.54 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1028 | GSESGIFTNTKESSSHHPGIAEFPSRG | Fibrinogen alpha chain | Serum | 2816.25 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) = 68, 223 and 1 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1029 | SSSYSKQFTSSTSYNRGDSTFES | Fibrinogen alpha chain | Serum | 2553.01 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) = 1.35, 1.31 and 1.5 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1030 | SSSYSKQFTSSTSYNRGDSTFESKS | Fibrinogen alpha chain | Serum | 2768.3 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Downregulated in cancer vs normal with Ratio of median intensity (patients/Controls) = 0.77, 0.03 and 0.98 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1031 | SSSYSKQFTSSTSYNRGDSTFESKSY | Fibrinogen alpha chain | Serum | 2931.29 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Downregulated in bladder cancer and upregulated in prostate cancer vs normal with Ratio of median intensity (patients/Controls) = 1.24, 0.13 and 0.97 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1032 | SSSYSKQFTSSTSYNRGDSTFESKSYKM | Fibrinogen alpha chain | Serum | 3190.4 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Downregulated in cancer vs normal with Ratio of median intensity (patients/Controls) = 0.52, 0 and 0.94 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1033 | SSSYSKQFTSSTSYNRGDSTFESKSYKMA | Fibrinogen alpha chain | Serum | 3261.4 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Downregulated in cancer vs normal with Ratio of median intensity (patients/Controls) = 0.33, 0.08 and 0.74 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1034 | SSYSKQFTSSTSYNRGDSTFE | Fibrinogen alpha chain | Serum | 2379.03 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "For bladder (Lower) and for breast (Higher) Differential ion intensity in cancer compare to normal with Ratio of median intensity (patients/Controls) = 1.57, 0.22 and 1.71 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1035 | NA | Fibrinogen alpha chain | Serum | 3206.34 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID1036 | NA | Fibrinogen alpha chain | Serum | 3277.39 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID1037 | DEAGSEADHEGTHSTKRGHAKSRPV | Fibrinogen alpha chain | Serum | 2659.03 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) = 1.37, 1.18 and 2.45 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1038 | SYKMADEAGSEADHEGTHSTKRGHAKSRPV | Fibrinogen alpha chain | Serum | 3239.22 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID1039 | HWESASLL | Complement C3f | Serum | 942.44 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "For Breast (Lower) and for Bladder (Higher) Differential ion intensity in cancer compare to normal with Ratio of median intensity (patients/Controls) = 1.74, 5.18 and 0.58 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1040 | IHWESASLL | Complement C3f | Serum | 1055.6 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) = 227, 1051 and 1 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1041 | RIHWESASLL | Complement C3f | Serum | 1211.7 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =7.86, 10.8 and 0.01 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1042 | HRIHWESASLL | Complement C3f | Serum | 1348.7 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID1043 | THRIHWESASLL | Complement C3f | Serum | 1449.76 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "For Prostate & bladder (Higher) Differential ion intensity in cancer compare to normal with Ratio of median intensity (patients/Controls) =1885, 2646 and 437 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1044 | ITHRIHWESASLL | Complement C3f | Serum | 1562.84 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Downregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =0.79, 1.13 and 0.54 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1045 | KITHRIHWESASLL | Complement C3f | Serum | 1690.9 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "For Prostate & bladder (Higher) Differential ion intensity in cancer compare to normal with Ratio of median intensity (patients/Controls) =4.05, 6.85 and 1.01 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1046 | SKITHRIHWESASLL | Complement C3f | Serum | 1777.94 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "For Prostate & bladder (Higher) Differential ion intensity in cancer compare to normal with Ratio of median intensity (patients/Controls) =4.37, 7.7 and 0.96 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1047 | SSKITHRIHWESASLL | Complement C3f | Serum | 1864.95 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "For Prostate & bladder (Higher) and for breast (Lower) Differential ion intensity in cancer compare to normal with Ratio of median intensity (patients/Controls) =2.18, 3.33 and 0.3 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1048 | SSKITHRIHWESASLLR | Complement C3f | Serum | 2021.06 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID1049 | SSKITHRIHWESASL | Complement C3f | Serum | 1751.88 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =1.82, 5.7 and 1.36 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1050 | NGFKSHALQLNNR | Complement C4 precursor | Serum | 1498.91 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =1, 809 and 1 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1051 | NGFKSHALQLNNRQ | Complement C4 precursor | Serum | 1626.85 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =1.09, 0.88 and 2.78 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1052 | NGFKSHALQLNNRQI | Complement C4 precursor | Serum | 1739.93 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =0.75, 0.66 and 2.75 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1053 | NGFKSHALQLNNRQIR | Complement C4 precursor | Serum | 1895.99 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =1.27, 3.33 and 2.95 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1054 | GLEEELQFSLGSKINV | Complement C4 precursor | Serum | 1762.87 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "For bladder (Lower) and for breast (Higher) Differential ion intensity in cancer compare to normal with Ratio of median intensity (patients/Controls) =1.62, 0.01 and 3.16 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1055 | GLEEELQFSLGSKINVKVGGNS | Complement C4 precursor | Serum | 2305.2 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =3.75, 2.56 and 3.49 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1056 | GLEEELQFSLGSKINVKVGGNSKGTL | Complement C4 precursor | Serum | 2704.13 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =61, 49 and 133 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1057 | GLEEELQFSLGSKINVKVGGNSKGTLKVLR | Complement C4 precursor | Serum | 3200.52 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID1058 | TLEIPGNSDPNMIPDGDFNSYVR | Complement C4 precursor | Serum | 2551.06 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID1059 | HAAYHPF | Inter-alpha-trypsin inhibitor heavy chain H4 | Serum | 842.4 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in Prostate cancer vs normal,Downregulated in Bladder cancer vs normal with Ratio of median intensity (patients/Controls) =1.49, 0.01 and 1.04 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1060 | GLPGPPDVPDHAAYHPF | Inter-alpha-trypsin inhibitor heavy chain H5 | Serum | 1786.86 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =2.39, 2.88 and 2.3 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1061 | QLGLPGPPDVPDHAAYHPF | Inter-alpha-trypsin inhibitor heavy chain H6 | Serum | 2028.01 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID1062 | SRQLGLPGPPDVPDHAAYHPF | Inter-alpha-trypsin inhibitor heavy chain H7 | Serum | 2271.14 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =4.58, 2.64 and 1.46 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1063 | SSRQLGLPGPPDVPDHAAYHPF | Inter-alpha-trypsin inhibitor heavy chain H8 | Serum | 2358.09 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =100, 73 and 531 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1064 | GVLSSRQLGLPGPPDVPDHAAYHPF | Inter-alpha-trypsin inhibitor heavy chain H9 | Serum | 2627.48 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Downregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =2.24, 0.26 and 1.07 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1065 | PGVLSSRQLGLPGPPDVPDHAAYHPF | Inter-alpha-trypsin inhibitor heavy chain H10 | Serum | 2724.48 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =1.75, 6.17 and 1.64 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1066 | MNFRPGVLSSRQLGLPGPPDVPDHAAYHPF | Inter-alpha-trypsin inhibitor heavy chain H11 | Serum | 3272.5 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =1, 1277 and 1 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1067 | QAGAAGSRMNFRPGVLSSRQLGLPGPPDVPDHAAYHPF | Inter-alpha-trypsin inhibitor heavy chain H12 | Serum | 3970.97 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =1, 957 and 1 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1068 | QLGLPGPPDVPDHAAYHPFR | Inter-alpha-trypsin inhibitor heavy chain H13 | Serum | 2183.91 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =1.71, 1.79 and 2.83 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1069 | HAAYHPFR | Inter-alpha-trypsin inhibitor heavy chain H14 | Serum | 998.45 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =121, 256 and 147 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1070 | NVHSGSTFFKYYLQGAKIPKPEASFSPR | Inter-alpha-trypsin inhibitor heavy chain H15 | Serum | 3156.52 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =3.43, 10.68 and 1.33 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1071 | NVHSAGAAGSRMNFRPGVLSS | PRO1851(ITIH4 splice variant) | Serum | 2115.01 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =3.22, 12.23 and 10.61 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1072 | ATEHLSTLSEKAKPALEDL | Apolipoprotein A-I | Serum | 2052.89 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =105, 306 and 1 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1073 | QGLLPVLESFKVSFLSALEEYTKKLNTQ | Apolipoprotein A-I | Serum | 3182.46 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =0.74, 6.36 and 1 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1074 | VSFLSALEEYTKKLNTQ | Apolipoprotein A-I | Serum | 1971.16 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =1, 641 and 1 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1075 | ELQEGARQKLHELQE | Apolipoprotein A-I | Serum | 1807.78 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID1076 | AELQEGARQKLHELQEKLSPLGEEMRDRA | Apolipoprotein A-I | Serum | 3377.45 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID1077 | ISASAEELRQRLAPLAEDVRGNL | Apolipoprotein A-IV | Serum | 2508.16 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =1.38, 1.2 and 7.96 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1078 | SLAELGGHLDQQVEEF | Apolipoprotein A-IV | Serum | 1771.81 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =148, 220 and 1 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1079 | GNTEGLQKSLAELGGHLDQQVEEF | Apolipoprotein A-IV | Serum | 2599.18 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID1080 | GNTEGLQKSLAELGGHLDQQVEEFR | Apolipoprotein A-IV | Serum | 2755.2 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =1.11, 12.37 and 1.22 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1081 | SLAELGGHLDQQVEEFR | Apolipoprotein A-IV | Serum | 1927.94 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =79, 671 and 1 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1082 | DVSSALDKLKEFGNTLEDKARELIS | Apolipoprotein C-I | Serum | 2778.15 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID1083 | TVGSLAGQPLQERAQAWGERL | Apolipoprotein E | Serum | 2267.07 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID1084 | AATVGSLAGQPLQERAQAWGERL | Apolipoprotein E | Serum | 2409.13 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =97, 2124 and 109 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1085 | AATVGSLAGQPLQERAQAWGERLR | Apolipoprotein E | Serum | 2565.45 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =1, 902 and 1 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1086 | HFFFPK | Clusterin precursor | Serum | 822.41 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =1.15, 4.66 and 0.76 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1087 | HFFFPKSRIV | Clusterin precursor | Serum | 1277.71 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =251, 1406 and 1 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1088 | RPPGFSPF | Bradykinin (and des-Arg bradykinin) | Serum | 904.48 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "For bladder (Lower) and for breast (Higher) Differential ion intensity in cancer compare to normal with Ratio of median intensity (patients/Controls) =1.06, 0.79 and 1.62 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1089 | RPPGFSPFR | Bradykinin (and des-Arg bradykinin) | Serum | 1060.57 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "For bladder (Lower) and for breast (Higher) Differential ion intensity in cancer compare to normal with Ratio of median intensity (patients/Controls) =0.77, 0.43 and 1.9 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1090 | NA | Bradykinin (and des-Arg bradykinin) | Serum | 920.41 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID1091 | NA | Bradykinin (and des-Arg bradykinin) | Serum | 1076.53 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID1092 | NLGHGHKHERDQGHGHQ | HMW Kininogen | Serum | 1943.88 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =1.58, 141 and 1 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1093 | KHNLGHGHKHERDQGHGHQ | HMW Kininogen | Serum | 2209.08 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =1.72, 2.07 and 1.56 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1094 | GHGLGHGHEQQHGLGHGHKF | HMW Kininogen | Serum | 2126.94 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID1095 | AVPPNNSNAAEDDLPTVELQGVVPR | Factor XIIIa | Serum | 2602.15 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =2.84, 2.3 and 4.73 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1096 | ALGISPFHEHAEVVFTANDSGPR | Transtherin precursor (‘prealbumin’) | Serum | 2451.11 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | "Upregulated in cancer vs normal with Ratio of median intensity (patients/Controls) =0.02, 1.17 and 3.07 in prostate, bladder and breast cancer respectively" | 16395409 |
| CancerPDF_ID1097 | PDAPRIKKIVQKKLAGDESAD | Platelet basic protein Precursor | Serum | 2279.18 | MALDI-TOF | "Advanced Prostate, Breast and Bladder cancer" | NA | 16395409 |
| CancerPDF_ID3409 | VLNLGPITR | Uromodulin | Urine | NA | CE-MS-TOF | Bladder cancer | Downregulated in cancer vs normal | 21591268 |
| CancerPDF_ID3410 | SGDSDDDEPPPLPRL | Membrane associated progesterone receptor component 1 | Urine | NA | CE-MS-TOF | Bladder cancer | Downregulated in cancer vs normal | 21591268 |
| CancerPDF_ID3411 | PpGEAGKpGEQGVPGDLG | Collagen alpha-1(I) chain | Urine | NA | CE-MS-TOF | Bladder cancer | Downregulated in cancer vs normal | 21591268 |
| CancerPDF_ID3412 | DGESGRpGRpGERGLpGPpG | Collagen alpha-1(III) chain | Urine | NA | CE-MS-TOF | Bladder cancer | Upregulated in cancer vs normal | 21591268 |
| CancerPDF_ID3417 | DCGDNSDEEN | Low-density lipoprotein receptor-related protein 2 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3418 | SAYQEAMDIS | "14-3-3 protein sigma, SFN" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3419 | PpGPpGpPGPpS | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3420 | GGpGSDGKpGPpG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3421 | TPEEKSAVTAL | Hemoglobin subunit beta | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3422 | PTALGVRGASRS | Bromodomain-containing protein 1 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3423 | KPLKEPGLGQL | Mitogen-activated protein kinase 14 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3424 | LSALEEYTKK | Apolipoprotein A-I | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3425 | DDGEAGKpGRpG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3426 | TCGDSCDQCCPG | Laminin subunit alpha-2 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3427 | DGPAGApGTPGpQG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3428 | GTCSGCNCNGHAS | Basement membrane-specific heparan sulfate proteoglycan core protein | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3429 | VDEVGGEALGRL | Hemoglobin subunit beta | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3430 | EAGGGSNSLQNSP | FERM domain-containing protein 4A | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3431 | KPWAAQDGPKPG | Leucine-rich repeat-containing protein 25 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3432 | EEYTKKLNTQ | Apolipoprotein A-I | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3433 | PGYTGNGYGPNGC | Cubilin | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3434 | KVVAGVANALAHK | Hemoglobin subunit delta | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3435 | MYVSGpPGpPGpP | "Collagen alpha-1(XVII) chain, COL17A1" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3436 | VHLTPEEKSAVT | Hemoglobin subunit beta | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3437 | VAGVANALAHKYH | Hemoglobin subunit beta | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3438 | AVADTRDQADGSR | Polymeric immunoglobulin receptor | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3439 | GSYNLPSLPDIDC | "Transcription intermediary factor 1-alpha, TRIM24" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3440 | GPPGpPGPpGPPGPPS | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3441 | GpPGEGLPGPpGpPGS | "Collagen alpha-1(XVII) chain, COL17A1" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3442 | ALEEYTKKLNTQ | Apolipoprotein A-I | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3443 | VVAGVANALAHKYH | Hemoglobin subunit beta | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3444 | DSDDDEPPPLPRL | "Membrane-associated progesterone receptor component 1, PGRMC1" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3445 | VGpPGPPGpPGPPGPPS | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3446 | PRGDqGqDGAAGPpGP | "Collagen alpha-1(XXIII) chain, COL23A1" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3447 | TKVPEPGSIKVPDQ | Small proline-rich protein 3 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3448 | KGDpGpAGLpGKDGpP | Collagen alpha-1(V) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3449 | DGQPGAKGEpGDAGAKG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3450 | ADSGEGDFLAEGGGVR | Fibrinogen alpha chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3451 | EDGHPGKPGRpGERG | Collagen alpha-2(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3452 | DpGPpGQSGRDGYPGp | Collagen alpha-1(XXIII) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3453 | PpGFGRpGDPGPPGPpG | Collagen alpha-1(XV) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3454 | GPpGPPGPPGPPGVSGGGY | Collagen alpha-2(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3455 | GSSVGTGTNLHSESASF | Serine/threonine-protein kinase D1 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3456 | GPpGPpGTSGHPGSpGSpG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3457 | TGDAGpVGPpGPpGPPGPP | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3458 | RINHTVILDDPFDD | Peptidyl-prolyl cis-trans isomerase-like 4 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3459 | PpGEAGKpGEQGVpGDLG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3460 | TGLSMDGGGSPKGDVDPF | Sodium/potassium-transporting ATPase subunit gamma | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3461 | EpGSpGENGApGQMGPRG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3462 | SDLHAHKLRVDPVNF | Hemoglobin subunit alpha | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3463 | pGqpGIKGDRGFpGEMG | Collagen alpha-1(X) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3464 | EEAPSLRPAPPPISGGGY | Fibrinogen beta chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3465 | WGKVNVDEVGGEALGRL | "Hemoglobin subunit beta, HBB" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3466 | IGTYCGQPVCENGCQNGG | "Fibrillin-2, FBN2" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3467 | GpAGSpGSNGApGQRGEpGP | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3468 | GEpGSpGENGAPGQmGpRG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3469 | DEPPQSPWDRVKDLAT | Apolipoprotein A-I | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3470 | NpGPPGpSGSpGKDGPpGPAG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3471 | EGSpGRDGSpGAKGDRGET | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3472 | pPGPTGPGGDKGDTGPpGPQG | "Collagen alpha-1(III) chain, COL3A1" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3473 | HLPAEFTPAVHASLDKF | Hemoglobin subunit alpha | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3474 | ADLADGVSGGEGKGGSDGGGSH | "CD99 antigen, CD99" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3475 | GApGApGGKGDAGAPGERGppG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3476 | TQPPEEETLSQAPESEE | "Rho guanine nucleotide exchange factor 25, ARHGEF25" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3477 | AARLEALKENGGARLAEY | Apolipoprotein A-I | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3478 | DGVWNGMIGEVFYQRAD | "Glutamate receptor ionotropic, NMDA1" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3479 | AAHLPAEFTPAVHASLDKF | Hemoglobin subunit alpha | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3480 | GppGESGREGApGAEGSPGRDG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3481 | KPGDGDSFYSDIPPGVSTNSA | Disintegrin and metalloproteinase domain-containing protein 22 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3482 | DEPPQSPWDRVKDLATVY | Apolipoprotein A-I | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3483 | GpTGpIGPpGpAGQPGDKGEGGAP | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3484 | EAEDLQVGQVELGGGPGAGSLQP | Insulin | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3485 | AAAAQGTAPPQDGEQPAESPEPP | Diacylglycerol kinase kappa | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3486 | NGDDGEAGKPGRpGERGPpGPQG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3487 | NGDDGEAGKPGRPGERGppGpQG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3488 | TFVCPTEIVAFSDKANEFHD | "Thioredoxin-dependent peroxide reductase, mitochondrial" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3489 | QNGEpGGKGERGApGEKGEGGppG | "Collagen alpha-1(III) chain, COL3A1" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3490 | EHGPPPPPDERDHSHGPPLPQ | Histidine-rich glycoprotein | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3491 | GDSMDRIEKDRLqGMAPAAGAD | "Collagen alpha-1(XVII) chain, COL17A1" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3492 | TGGPpGENGKPGEpGpKGDAGApGAP | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3493 | GPIGppGVRGSVGEAGpEGPPGEpGP | Collagen alpha-2(V) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3494 | GPpGKNGDDGEAGKpGRpGERGPPGP | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3495 | ELDCWDGKGEDQEPIITHGKAMC | "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4, PLCB4" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3496 | LAPEPLSAPPGSPPPSAAPTSATSNSSN | Homeobox protein Hox-B3 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3497 | NRGERGSEGSPGHpGQPGPpGPPGApGP | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3498 | DGKTGPpGpAGQDGRPGPPGpPGARGQAG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3499 | ERGEAGIpGVpGAKGEDGKDGSpGEpGA | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3500 | DGVSGGEGKGGSDGGGSHRKEGEEADAPG | "CD99 antigen, CD99" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3501 | GGEGKGGSDGGGSHRKEGEEADAPGVIPG | CD99 antigen | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3502 | EVEMKPDSSPSEVPEGVSETEGALQI | SH3 and multiple ankyrin repeat domains protein 2 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3503 | GPPGESGREGApGAEGSPGRDGSPGAKGDR | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3504 | TGARGLVGEpGpAGSKGESGNKGEpGSAGPQ | Collagen alpha-2(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3505 | SPADKTNVKAAWGKVGAHAGEYGAEALER | Hemoglobin subunit alpha | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3506 | DGLQAAFTTAHELGHVFNMPHDDAKQCA | "A disintegrin and metalloproteinase with thrombospondin motifs 1, ADAMTS1" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3507 | LTPEEKSAVTALWGKVNVDEVGGEALGRL | "Hemoglobin subunit beta, HBB" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3508 | pGPPGSpGPAGPTGKQGDRGEAGAQGPMGpSGpAG | Collagen alpha-1(II) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3509 | GLPGPKGEKGApGDFGpRGDQGQDGAAGpPGPpG | Collagen alpha-1(XXIII) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3510 | VLSPADKTNVKAAWGKVGAHAGEYGAEALER | Hemoglobin subunit alpha | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3511 | PAGDRGPRGERGPpGppGRDGEDGPTGPPGPpGP | Collagen alpha-2(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3512 | VLSPADKTNVKAAWGKVGAHAGEYGAEALERm | Hemoglobin subunit alpha | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3513 | PpGPSGpRGQPGVMGFpGPKGNDGAPGKNGERGGPGG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3514 | DGTESSEDSFSFTVTDGTHTDFYVFPDTVFE | "FRAS1-related extracellular matrix protein 2, FREM2" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3515 | DGQPGPKGDQGEKGERGTPGIGGFpGPSGNDGSAGpPGpp | Collagen alpha-1(VII) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3516 | RERpQNQQpHRAQRSPQQqPSRLHRpQNQE | Collagen alpha-2(XI) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3517 | SNGNpGPPGPSGSPGKDGPPGpAGNTGApGSpGVSGPKGDAGQPG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3518 | GAGPGSGSnVSMNQQNPqAPQAqSLGGMHVNGAPPLMqASMQGGVPAPGQMP | Cleavage stimulation factor subunit 2 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3519 | DGETGAAGppGPAGPAGERGEqGAPGPSGFQGLPGPPGPPGEGGKpGDQGVPGEAGAPG | "Collagen alpha-1(II) chain, COL2A1" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3520 | IQRTPKIQVYSRHPAENGKSNFLNcYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYAcRVNHVTLSQPKIVKWDRDM | Beta-2-microglobulin | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3521 | IQRTPKIQVYSRHPAENGKSNFLNcYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYAcRVNHVTLSQPKIVKWDRDm | Beta-2-microglobulin | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between primary UBC and normal individual | 27026199 |
| CancerPDF_ID3522 | PpGEAGKpG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3523 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3524 | KLGHPDTL | Protein S100-A9 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3525 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3526 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3527 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3528 | YQTNKAKH | Cystatin-B | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3529 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3530 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3531 | pGDRGEpGPp | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3532 | SpGPDGKTGpP | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3533 | GEDGRpGPpGP | Collagen alpha-1(II) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3534 | DGEAGKpGRpG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3535 | RYVGGQEHF | Alpha-1-acid glycoprotein 1 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3536 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3537 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3538 | SAYQEAMDIS | "14-3-3 protein sigma, SFN" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3539 | RAHGQESAIF | Secreted and transmembrane protein 1 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3540 | DGESGRpGRpG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3541 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3542 | PpGEAGKpGEQG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3543 | PTALGVRGASRS | Bromodomain-containing protein 1 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3544 | KPLKEPGLGQL | Mitogen-activated protein kinase 14 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3545 | LSALEEYTKK | Apolipoprotein A-I | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3546 | GHPGQPGpPGPpG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3547 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3548 | TCGDSCDQCCPG | Laminin subunit alpha-2 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3549 | GTCSGCNCNGHAS | Basement membrane-specific heparan sulfate proteoglycan core protein | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3550 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3551 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3552 | ApGDRGEpGPPGp | "Collagen alpha-1(I) chain, Collagen alpha- 1(I) chain (Alpha-1 type I collagen)" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3553 | KPWAAQDGPKPG | Leucine-rich repeat-containing protein 25 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3554 | EEYTKKLNTQ | Apolipoprotein A-I | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3555 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3556 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3557 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3558 | KVVAGVANALAHK | Hemoglobin subunit delta | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3559 | VGTSAAPVPSDNH | Apolipoprotein E | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3560 | SpGSPGPDGKTGPp | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3561 | SpGSpGPDGKTGPp | Collagen alpha1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3562 | MYVSGpPGpPGpP | Collagen alpha-1(XVII) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3563 | GSpGAKGDRGETGP | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3564 | VHLTPEEKSAVT | Hemoglobin subunit beta | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3565 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3566 | GLpGPpGERGGpGS | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3567 | VAGVANALAHKYH | Hemoglobin subunit beta | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3568 | GEDGpEGpKGRAGP | Collagen alpha-1(XI) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3569 | AILDETKGDYEK | Annexin A1 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3570 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3571 | PpGPAGNPGpSpNSp | Collagen alpha-1(XXVI) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3572 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3573 | GpPGEGLPGPpGpPGS | Collagen alpha-1(XVII) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3574 | DEDEDEDNACLR | Pleckstrin homology domain-containing family G member 5 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3575 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3576 | ERAEDEEEINAE | Myosin-3 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3577 | ALEEYTKKLNTQ | Apolipoprotein A-I | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3578 | GLpGTGGPpGENGKpG | Collagen alpha1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3579 | GLpGTGGPpGENGKpG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3580 | VVAGVANALAHKYH | Hemoglobin subunit beta | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3581 | DEPPQSPWDRVK | Apolipoprotein A-I | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3582 | SQDASDGLQRLHM | Endothelial protein C receptor | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3583 | GARGEPGpTGLpGPpG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3584 | DSDDDEPPPLPRL | "Membrane-associated progesterone receptor component 1, PGRMC1" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3585 | GPPGkNGDDGEAGKPG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3586 | DGLAHLDNLKGTFA | Hemoglobin subunit beta | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3587 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3588 | DGSpGAKGDRGETGPA | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3589 | TKVPEPGSIKVPDQ | Small proline-rich protein 3 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3590 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3591 | NGERIEKVEHSDL | "Beta-2-microglobulin form pI 5,3; B2M" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3592 | ApGNDGAKGDAGApGApG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3593 | GLpGpPGSNGNPGPpGp | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3594 | ADSGEGDFLAEGGGVR | Fibrinogen alpha chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3595 | SLGSPSGEVSHPRKT | Alpha-2-HS-glycoprotein | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3596 | GIPmGPmPAAGmPYL | Synergin gamma | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3597 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3598 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3599 | DEPPQSPWDRVKD | Apolipoprotein A-I | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3600 | EGSPGHPGQpGPpGPpG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3601 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3602 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3603 | QGpRGQpGPPGpPGApG | Collagen alpha-1(XXIV) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3604 | SGSRPSPEQATANFF | Corticoliberin | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3605 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3606 | DpGPpGQSGRDGYPGp | Collagen alpha-1(XXIII) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3607 | PpGFGRpGDPGPPGPpG | Collagen alpha-1(XV) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3608 | GInGSPGGKGEMGpAGIP | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3609 | GPpGPPGPPGPPGVSGGGY | Collagen alpha-2(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3610 | VLTGYQVDKNKDDE | Cystatin-A | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3611 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3612 | PGApGFPGSKGEpGDIL | Collagen alpha-5(IV) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3613 | FSDGLAHLDNLKGTF | Hemoglobin subunit beta | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3614 | GSSVGTGTNLHSESASF | Serine/threonine-protein kinase D1 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3615 | LSALEEYTKKLNTQ | Apolipoprotein A-I | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3616 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3617 | VGpPGpPGPpGPpGPPSAG | "Collagen alpha01(I) chain, Collagen alpha01(I) chain (Alpha01 type I collagen)" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3618 | TFTDTEDPAKFKMK | Retinol-binding protein 4 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3619 | GPpGPpGTSGHPGSpGSpG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3620 | TGDAGpVGPpGPpGPPGPP | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3621 | RINHTVILDDPFDD | Peptidyl-prolyl cis-trans isomerase-like 4 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3622 | DEAGSEADHEGTHSTK | Fibrinogen alpha chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3623 | GNSGEpGApGSKGDTGAKG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3624 | SpGRDGSpGAKGDRGET | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3625 | PpGPPGkNGDDGEAGKpG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3626 | DHDVGSELPPEGVLGAL | ProSAAS | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3627 | GPpGLDGQPGAPGLpGPPG | Collagen alpha-5(IV) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3628 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3629 | EpGSPGENGApGQMGPRG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3630 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3631 | TGLSMDGGGSPKGDVDPF | Sodium/potassium-transporting ATPase subunit gamma | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3632 | EpGSpGENGApGQMGPRG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3633 | GPpGPTGPGGDKGDTGPpGP | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3634 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3635 | SDLHAHKLRVDPVNF | Hemoglobin subunit alpha | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3636 | pGqpGIKGDRGFpGEMG | Collagen alpha-1(X) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3637 | EpGSpGENGApGQmGPRG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3638 | EGHpGLpGFPGpEGPpGP | Collagen alpha-5(IV) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3639 | PGPAGARGnDGATGAAGPpGP | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3640 | QGPGGPpGPKGNSGEpGApG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3641 | NDGARGSDGQPGPPGppGT | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3642 | EAGSEADHEGTHSTKRG | Fibrinogen alpha chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3643 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3644 | GMEPQVPFSDYMELQ | Zinc finger protein basonuclin-1 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3645 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3646 | EEAPSLRPAPPPISGGGY | Fibrinogen beta chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3647 | NDGARGSDGQPGPPGppGT | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3648 | WGKVNVDEVGGEALGRL | "Hemoglobin subunit beta, HBB" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3649 | IGTYCGQPVCENGCQNGG | "Fibrillin-2, FBN2" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3650 | GEpGSpGENGApGQMGPRG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3651 | NDGAKGDAGApGApGSQGApG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3652 | GEpGSpGENGApGQMGPRG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3653 | VGPpGPpGPpGPpGPPSAGF | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3654 | GLpGTGGPpGENGKPGEPGP | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3655 | GpAGSpGSNGApGQRGEpGP | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3656 | GEpGSpGENGAPGQmGpRG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3657 | GLpGTGGPpGENGKPGEPGp | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3658 | GpPGEGRAGEpGTAGpTGpP | Collagen alpha-2(VIII) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3659 | pGPpGTSGHpGSPGSPGYQG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3660 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3661 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3662 | AADHDVGSELPPEGVLGAL | ProSAAS | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3663 | GpEGAQGPRGEpGTPGSpGP | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3664 | DEPPQSPWDRVKDLAT | Apolipoprotein A-I | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3665 | NpGPPGpSGSpGKDGPpGPAG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3666 | NSGEpGApGSKGDTGAKGEp | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3667 | EGSpGRDGSpGAKGDRGET | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3668 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3669 | pPGPTGPGGDKGDTGPpGPQG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3670 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3671 | HLPAEFTPAVHASLDKF | Hemoglobin subunit alpha | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3672 | ADLADGVSGGEGKGGSDGGGSH | "CD99 antigen, CD99" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3673 | PGppGpRGPSGAPGADGpQGP | Collagen alpha-1(V) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3674 | DDGEAGKPGRpGERGPpGp | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3675 | GApGApGGKGDAGAPGERGppG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3676 | EGIPRLDSQPQETSPEL | TRAF-type zinc finger domain-containing protein 1 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3677 | SGEpGApGSKGDTGAKGEpGP | "Collagen alpha-1(I) chain, Collagen alpha- 1(I) chain (Alpha-1 type I collagen)" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3678 | RGEPGPpGPAGAAGPAGnpGAD | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3679 | NGApGNDGAKGDAGApGApGSQ | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3680 | TTSVIPEAGTPYPDPLEQ | Radial spoke head protein 4 homolog A | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3681 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3682 | AARLEALKENGGARLAEY | Apolipoprotein A-I | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3683 | LSMDNNRNLDLDSIIAE | Keratin | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3684 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3685 | pGAAGNpGAPGHVGApGPSGPpG | Collagen alpha-1(XXII) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3686 | FSVDETGQMSATAKGRVR | Retinol-binding protein 4 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3687 | GEKGpSGEAGTAGPpGTpGPQG | Collagen alpha-2(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3688 | SGIDGSPGEKGDPGDVGGPGpP | Collagen alpha-3(V) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3689 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3690 | AVEPDRRNQSPVDQGATGA | Syndecan-1 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3691 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3692 | pGPpGEKGENGDVGPMGPpGP | Collagen alpha-1(XI) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3693 | GEKGpSGEAGTAGPpGTpGPQG | Collagen alpha-2(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3694 | AAHLPAEFTPAVHASLDKF | Hemoglobin subunit alpha | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3695 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3696 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3697 | PDGGLVVLSGGGTSGRMAFLm | Glucokinase regulatory protein | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3698 | GppGESGREGApGAEGSPGRDG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3699 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3700 | GTDVKDIPFNLTNNIPGCE | Coiled-coil domain-containing protein 144B | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3701 | GSNGNpGpPGPSGSpGKDGPpGP | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3702 | NGDDGEAGKpGRpGERGPPGP | "Collagen alpha-1(I) chain, Collagen alpha- 1(I) chain (Alpha-1 type I collagen)" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3703 | NGDDGEAGKpGRPGERGpPGp | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3704 | PGSSGTGGTATWKPGSSGPGSTGS | Fibrinogen alpha chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3705 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3706 | GPGMRGMPGSPGGpGSDGKpGpP | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3707 | GpPGEAGKpGEQGVpGDLGAPGp | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3708 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3709 | DEPPQSPWDRVKDLATVY | Apolipoprotein A-I | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3710 | PGPpGPKGVDGLPGDMGppGTpG | Collagen alpha-1(IV) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3711 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3712 | GDAGApGAPGGKGDAGApGERGpPG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3713 | GpTGpIGPpGpAGQPGDKGEGGAP | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3714 | pLGpQGEKGVMGYPGPPGVpGp | Collagen alpha-1(XXIV) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3715 | NSGEKGDQGFQGQPGFPGPPGP | Collagen alpha-1(XVI) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Urinary bladder Cancer (UBC) | Differential expression between recurrence of UBC and recurrence control | 27026199 |
| CancerPDF_ID3716 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3717 | ADGQPGAKGEPGDAGAKGDAGPpGP | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3718 | NDGPpGRDGQpGHKGERGYpG | Collagen alpha-2(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3719 | VPNQEFGLSENEPGTNFVYA | Gastricsin | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3720 | AAAAQGTAPPQDGEQPAESPEPP | Diacylglycerol kinase kappa | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3721 | ADGQpGAKGEpGDAGAKGDAGPPGp | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3722 | GNSGEKGDQGFQGQPGFPGPpGP | Collagen alpha-1(XVI) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3723 | ADGQpGAKGEpGDAGAKGDAGppGP | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3724 | KGDAGApGApGGKGDAGApGERGpPG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3725 | ANGApGNDGAKGDAGApGApGSQGAPG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3726 | TFVCPTEIVAFSDKANEFHD | "Thioredoxin-dependent peroxide reductase, mitochondrial" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3727 | GLpGpAGpPGEAGKPGEQGVpGDLG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3728 | EGGKGPRGETGpAGRpGEVGppGP | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3729 | QNGEpGGKGERGApGEKGEGGppG | "Collagen alpha-1(III) chain, COL3A1" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3730 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3731 | PpGppGPpGVPGSDGIDGDNGPPGK | Collagen alpha-2(IX) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3732 | PSGPpGPAGSPGERGAAGSGGPIGpPG | Collagen alpha-2(XI) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3733 | PPYPPQEQRSRPYLHGTRH | LIM domain-containing protein 1 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3734 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3735 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3736 | GANGApGNDGAKGDAGApGApGSQGApG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3737 | KGNSGEPGApGSKGDTGAKGEPGpVG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3738 | SEAEDASLLSFMQGYMKHATK | Apolipoprotein C-III | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3739 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3740 | EEVEVAQVQVPTPARDSAGVPAP | TRMT1-like protein | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3741 | EEVEVAQVQVPTPARDSAGVPAP | TRMT1-like protein | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3742 | KGNSGEpGAPGSKGDTGAKGEpGpVG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3743 | KNGDDGEAGKpGRPGERGpPGPQG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3744 | KGNSGEpGApGSKGDTGAKGEpGpVG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3745 | GPIGppGVRGSVGEAGpEGPPGEpGP | Collagen alpha-2(V) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3746 | SGNAGPpGPPGPAGKEGGKGpRGETGP | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3747 | DFVPPVVRWLNEQRYYGGGY | Complement C3 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3748 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3749 | TQQPQQDEMPSPTFLTQVKES | Apolipoprotein C-IV | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3750 | ADGQpGAKGEpGDAGAKGDAGPpGPAGP | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3751 | LMIEQNTKSPLFMGKVVNPTQK | Alpha-1-antitrypsin | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3752 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3753 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3754 | GMKGDPGLPGVPGFpGmKGpSGVPGSAG | Collagen alpha-5(IV) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3755 | DEAGSEADHEGTHSTKRGHAKSRP | "Fibrinogen alpha chain, Fibrinogen alpha chain" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3756 | ApGPAGSRGApGPQGpRGDKGETGERG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3757 | GApGQNGEPGGKGERGApGEKGEGGppG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3758 | PGVPGKDGQAGQpGQPGPKGDpGISGTP | Collagen alpha-1(IV) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3759 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3760 | pGKDGETGAAGPpGPAGPAGERGEqGApG | Collagen alpha-1(II) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3761 | LAPEPLSAPPGSPPPSAAPTSATSNSSN | Homeobox protein Hox-B3 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3762 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3763 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3764 | DEAGSEADHEGTHSTKRGHAKSRPV | Fibrinogen alpha chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3765 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3766 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3767 | SGHPGSPGSPGYQGPpGEPGQAGPSGPpGP | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3768 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3769 | SQYLSSVDSFGSPPTAAASQETDQLE | Protein fosB | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3770 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3771 | AVADTRDQADGSRASVDSGSSEEQGGSS | Polymeric immunoglobulin receptor | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3772 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3773 | GPpGADGQpGAKGEpGDAGAKGDAGpPGPAGP | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3774 | GPPGESGREGApGAEGSPGRDGSPGAKGDR | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3775 | VQGPpGpAGEEGKRGARGEPGPTGLpGPpG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3776 | TGARGLVGEpGpAGSKGESGNKGEpGSAGPQ | Collagen alpha-2(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3777 | GRDGNpGNDGPpGRDGQpGHKGERGYpG | Collagen alpha-2(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3778 | RQQLPVGTTWGPFPGKmDLNNNSLKT | Zinc finger protein ZFPM2 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3779 | KGETGDVGqMGPPGPPGPRGpSGAPGADGPQGP | Collagen alpha-1(V) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3780 | ESELMRDAQLNDGAmETGTLYLAEEDP | Proenkephalin-B | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3781 | DGLQAAFTTAHELGHVFNMPHDDAKQCA | "A disintegrin and metalloproteinase with thrombospondin motifs 1, ADAMTS1" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3782 | VGpTGATGDKGPPGPVGPPGSNGpVGEpGpEGPA | Collagen alpha-2(V) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3783 | pGPPGSpGPAGPTGKQGDRGEAGAQGPMGpSGpAG | Collagen alpha-1(II) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3784 | SPGIPGSKGEqGFmGpPGPqGQPGLPGSPGHAT | Collagen alpha-1(IV) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3785 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3786 | ATSVNSVTGIRIEDLPTSESTVHAQEQSPS | "Podoplanin, PDPN" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3787 | GLPGPKGEKGApGDFGpRGDQGQDGAAGpPGPpG | Collagen alpha-1(XXIII) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3788 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3789 | QGpPGKNGETGPQGPPGPTGPGGDKGDTGPpGPQG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3790 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3791 | VLSPADKTNVKAAWGKVGAHAGEYGAEALER | Hemoglobin subunit alpha | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3792 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3793 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3794 | AAGEpGKAGERGVpGPpGAVGPAGKDGEAGAQGPPGP | "Collagen alpha-1(I) chain, Collagen alpha-1(I) chain (Alpha-1 type I collagen)" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3795 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3796 | GQPGTKGGpGDQGEPGPQGLpGFSGPpGKEGEpGP | Collagen alpha-2(IX) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3797 | PRGERGpQGNSGEKGDQGFQGQPGFPGpPGPpG | Collagen alpha-1(XVI) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3798 | ERGppGESGAAGPTGpIGSRGPSGPPGPDGNKGEpG | Collagen alpha-2(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3799 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3800 | VLSPADKTNVKAAWGKVGAHAGEYGAEALERm | Hemoglobin subunit alpha | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3801 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3802 | QGKTGpPGPPGVVGpQGPTGETGPMGERGHpGPpGP | Collagen alpha-1(V) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3803 | pGAKGEVGpAGSpGSNGAPGQRGEPGPQGHAGAQGpPG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3804 | PpGPAGFAGPPGADGQPGAKGEpGDAGAKGDAGPPGPAGP | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3805 | EPSCSVSSCAQPVCCEPAICEPSCSVSSCCQPVGS | Keratin-associated protein 16-1 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3806 | VLSPADKTNVKAAWGKVGAHAGEYGAEALERm | Hemoglobin subunit alpha | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3807 | QGPPGLKGAKGEpGSNGDqGPKGDRGVPGIKGDRGEP | Collagen alpha-1(VII) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3808 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3809 | GPPGPAGFAGPPGADGQpGAKGEpGDAGAKGDAGPpGPAGPAG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3810 | FAGpPGADGQPGAKGEpGDAGAKGDAGPpGPAGPAGPpGPIG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3811 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3812 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3813 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3814 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3815 | RERpQNQQpHRAQRSPQQqPSRLHRpQNQE | Collagen alpha-2(XI) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3816 | GLGGnFAAQMAGGFDEKAGGAQLGVMQGPmGPMGPRGpPG | Collagen alpha-1(II) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3817 | GppGPRGPQGPNGADGPqGPPGSVGSVGGVGEKGEPGEAGnPG | Collagen alpha-1(XI) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3818 | QKGQAGEKGRAGMPGGPGKSGSmGPVGPPGpAGERGHpGA | Collagen alpha-1(XVI) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3819 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3820 | SNGNpGPPGPSGSPGKDGPPGpAGNTGApGSpGVSGPKGDAGQPG | Collagen alpha-1(III) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3821 | GNDGATGAAGPPGPTGpAGPPGFPGAVGAKGEAGpQGpRGSEGpQG | Collagen alpha-1(I) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3822 | GLGGnFAAQMAGGFDEKAGGAQLGVMQGPmGPMGPRGpPG | Collagen alpha-1(II) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3823 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3824 | AGNDGTpGRDGAVGERGDRGDpGPAGLPGSqGAPGTPGPVGApGDA | Collagen alpha-2(V) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3825 | GQGSSEDDLQEEEQIEQAIKEHLNQGSSQETDKLAPVS | Secretogranin-2 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3826 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3827 | GApGQpGMAGVDGpPGPKGNMGPQGEPGPPGQQGNPGPQGLPGPQGp | Collagen alpha-1(XI) chain | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3828 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3829 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3830 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3831 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3832 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3833 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3834 | EKDHLVNDYEQNmKLLQTKYDADINLLKQEHALSASKASSMIE | Centrosomal protein of 112 kDa | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3835 | GAGPGSGSnVSMNQQNPqAPQAqSLGGMHVNGAPPLMqASMQGGVPAPGQMP | Cleavage stimulation factor subunit 2 | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3836 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3837 | DGETGAAGppGPAGPAGERGEqGAPGPSGFQGLPGPPGPPGEGGKpGDQGVPGEAGAPG | "Collagen alpha-1(II) chain, COL2A1" | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3838 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3839 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3840 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3841 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3842 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3843 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3844 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3845 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3846 | IQRTPKIQVYSRHPAENGKSNFLNcYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYAcRVNHVTLSQPKIVKWDRDM | Beta-2-microglobulin | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3847 | IQRTPKIQVYSRHPAENGKSNFLNcYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYAcRVNHVTLSQPKIVKWDRDm | Beta-2-microglobulin | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID3848 | NA | NA | Urine | NA | "CE-MS, Micro-TOF-MS" | Bladder cancer | Differentially expressed between recurrence of UBC vs recurrence control | 27026199 |
| CancerPDF_ID8650 | MPMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA | Macrophage migration inhibitory protein | Serum | NA | FPLC | Bladder cancer | NA | 19762145 |
| CancerPDF_ID9954 | SFSKDWSF | Beta-2-microglobulin | Urine | 1003.4501 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9955 | QKAREDIF | Zinc-alpha-2-glycoprotein | Urine | 1006.5155 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9956 | DVSLQLPSR | Complement C3 | Urine | 1014.5541 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9957 | HALSKYGAAT | Alpha-2-macroglobulin | Urine | 1018.5306 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9958 | FRLLGNVLV | Hemoglobin subunit beta | Urine | 1030.638 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9959 | QGLLLLDFGG | Hermansky-Pudlak syndrome 6 protein | Urine | 1032.6155 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9960 | RVLGKDCNE | Band 4.1-like protein 4A | Urine | 1033.5446 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9961 | RTERGRKM | Myosin-4 | Urine | 1033.5371 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9962 | SKDWSFYL | Beta-2-microglobulin | Urine | 1045.5074 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9963 | VNCLSDLVGQ | Nesprin-1 | Urine | 1047.5336 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9964 | SGSVIDQSRV | Uromodulin | Urine | 1047.5336 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9965 | VVYPWTQR | Hemoglobin subunit beta | Urine | 1048.5583 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9966 | LNNFYPRE | Ig kappa chain C region | Urine | 1052.5468 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9967 | GPKWPEPVF | Mannan-binding lectin serine protease 2 | Urine | 1056.5455 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9968 | RPPGFSPFR | Kininogen-1 | Urine | 1060.5946 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9969 | FKAWAVARL | Serum albumin precursor | Urine | 1061.6096 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9970 | KSQVVAGTNY | Cystatin-B | Urine | 1066.5416 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9971 | GHVLAKELEA | Insulin-like growth factor II | Urine | 1066.6003 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9972 | GLDPGLDHML | "Alpha-aminoadipic semialdehyde synthase, mitochondrial" | Urine | 1067.4723 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9973 | GEYKFQNAL | Serum albumin precursor | Urine | 1069.5603 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9974 | IQRTPKIQV | Beta-2-microglobulin | Urine | 1082.6496 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9975 | YGRAPQLRE | Protein AMBP | Urine | 1089.568 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9976 | PITFGQGTRL | Ig kappa chain V-II region TEW | Urine | 1089.5879 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9977 | YRSPHWGST | Prostaglandin-H2 D-isomerase | Urine | 1090.4961 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9978 | FVLKTPSAAY | Gelsolin | Urine | 1096.6118 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9979 | PILRHGIQY | Kininogen-1 | Urine | 1096.616 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9980 | FSSPHGKDLL | Serotransferrin precursor | Urine | 1100.5738 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9981 | PLGPQGPPGPQG | WD repeat-containing protein 33 | Urine | 1101.5565 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9982 | MGKVVNPTQK | Alpha-1-antitrypsin | Urine | 1101.5892 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9983 | LPGPTPGLRPP | Akirin-1 | Urine | 1101.6265 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9984 | LPGPPGLPGIGK | Collagen alpha-1(VIII) chain | Urine | 1102.6129 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9985 | ISRLEPEDF | Ig kappa chain V-III region NG9 (Fragment) | Urine | 1105.5325 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9986 | RLLHVAVSDV | 26S proteasome non-ATPase regulatory subunit 1 | Urine | 1108.5962 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9987 | RPEVHSKEQ | Zinc finger protein 397OS | Urine | 1109.5634 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9988 | SQRFPKAEF | Serum albumin precursor | Urine | 1109.5951 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9989 | PRYPVGKFF | Insulin-like growth factor II | Urine | 1110.5979 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9990 | RAHGQESAIF | Secreted and transmembrane protein 1 | Urine | 1115.5425 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9991 | LSFSKDWSF | Beta-2-microglobulin | Urine | 1116.5437 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9992 | AKLYGRAPQL | Protein AMBP | Urine | 1116.6341 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9993 | HEGPGGAVSTSQ | Uncharacterized protein C14orf43 | Urine | 1126.5159 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9994 | GIPGPLGHPGPQ | Collagen alpha-1(XVII) chain | Urine | 1126.5459 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9995 | ITKQKWEAE | Zinc-alpha-2-glycoprotein | Urine | 1132.591 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9996 | GLPGPTGIPGPIG | Collagen alpha-5(IV) chain | Urine | 1132.6275 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9997 | REPVDTGPPAP | Uncharacterized protein C2orf82 | Urine | 1135.589 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9998 | YVVHTNYDE | Protein AMBP | Urine | 1139.4901 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9999 | GPLGIPGSSGFPG | Collagen alpha-2(V) chain | Urine | 1142.5315 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10000 | IGPPGPPGLPGPS | Collagen alpha-5(IV) chain | Urine | 1142.5651 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10001 | GPPGEPGLPGIPG | Collagen alpha-1(VIII) chain | Urine | 1144.5432 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10002 | REPGVAGGDVCS | Homeobox protein Meis1 | Urine | 1146.5304 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10003 | RVAPEEHPVL | "Actin, cytoplasmic 1" | Urine | 1146.6317 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10004 | LAAWQELCQS | Conserved oligomeric Golgi complex subunit 7 | Urine | 1148.4899 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10005 | WRQVEGMED | Zinc-alpha-2-glycoprotein | Urine | 1149.4816 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10006 | DVNKYLGRW | Apolipoprotein D | Urine | 1150.6011 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10007 | HYGALAGDKLI | Ankyrin repeat domain-containing protein 24 | Urine | 1157.5842 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10008 | GPLGPQGPPGPQG | WD repeat-containing protein 33 | Urine | 1158.536 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10009 | GPIGPPGPAGAPGD | Collagen alpha-1(I) chain | Urine | 1159.5427 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10010 | KIRPFFPQQ | Fibrinogen beta chain | Urine | 1160.6606 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10011 | LVVYPWTQR | Hemoglobin subunit beta | Urine | 1161.6392 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10012 | KQRNFDKIL | Myosin-2 | Urine | 1161.6557 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10013 | GLPGMPGHDGAPG | Collagen alpha-5(IV) chain | Urine | 1162.5267 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10014 | AFRQGHNSVF | Hemopexin | Urine | 1162.5769 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10015 | YARRHPDYS | Serum albumin precursor | Urine | 1164.5616 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10016 | RNVEVIMCVC | Dedicator of cytokinesis protein 2 | Urine | 1165.4962 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10017 | ERIRERSKP | Matrix Gla protein | Urine | 1170.6794 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10018 | YGSKEDPQTF | Serotransferrin precursor | Urine | 1171.5517 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10019 | DQGPVGRTGEVG | Collagen alpha-2(I) chain | Urine | 1171.564 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10020 | QQDKFLGRW | Prostaglandin-H2 D-isomerase | Urine | 1177.6029 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10021 | LRVLRAQPVQ | Gelsolin | Urine | 1179.7158 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10022 | GEYKFQNALL | Serum albumin precursor | Urine | 1182.6102 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10023 | VKHSTIFENL | Serotransferrin precursor | Urine | 1187.6475 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10024 | LAVRYSRGRL | Vesicular integral-membrane protein VIP36 | Urine | 1190.6974 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10025 | VVYPWTQRF | Hemoglobin subunit beta | Urine | 1195.629 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10026 | YEKTDTDGKF | Protein AMBP | Urine | 1203.5398 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10027 | HVDGPPPRPQL | Alpha-1B-glycoprotein | Urine | 1212.6356 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10028 | VRWLQGSQEL | Ig alpha-2 chain C region | Urine | 1215.6412 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10029 | VIKGARDSHAGL | Secreted and transmembrane protein 1 | Urine | 1223.6697 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10030 | IERYPGSPGSY | Glutaminyl-peptide cyclotransferase | Urine | 1225.5666 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10031 | SRVLNLGPITR | Uromodulin | Urine | 1225.7265 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10032 | VDETYVPKEF | Serum albumin precursor | Urine | 1226.5773 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10033 | LAHLDNLKGTF | Hemoglobin subunit beta | Urine | 1228.6683 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10034 | YQQKPGQAPVL | Ig lambda chain V-V region DEL | Urine | 1228.68 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10035 | YVIIKPLVWV | Serum amyloid P-component | Urine | 1229.7657 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10036 | AAQYDGKGVGLGP | Collagen alpha-2(I) chain | Urine | 1232.6424 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10037 | AAFRQGHNSVF | Hemopexin | Urine | 1233.6132 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10038 | RKPQYEQLTA | "Bullous pemphigoid antigen 1, isoforms 6/9/10" | Urine | 1233.6192 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10039 | VVKQGFEPPSF | Gelsolin | Urine | 1234.6472 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10040 | WKYYYDGKD | Zinc-alpha-2-glycoprotein | Urine | 1237.5395 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10041 | PVTKSFNRGEC | Ig kappa chain C region | Urine | 1237.5869 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10042 | FIQASYEPLGI | B-cell CLL/lymphoma 6 member B protein | Urine | 1237.6881 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10043 | PTTKTYFPHF | Hemoglobin subunit alpha | Urine | 1238.623 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10044 | PRYPVGKFFQ | Insulin-like growth factor II | Urine | 1238.6583 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10045 | AAVQPVIGISQR | Phosphoinositide-3-kinase-interacting protein 1 | Urine | 1238.7374 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10046 | WVRQAPGKGLE | Ig heavy chain V-III region WEA | Urine | 1240.6674 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10047 | VNWIDSIIQR | Leukocyte elastase | Urine | 1243.6792 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10048 | GRLASPGFPGEY | Mannan-binding lectin serine protease 2 | Urine | 1250.5962 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10049 | YRSPHWGSTY | Prostaglandin-H2 D-isomerase | Urine | 1253.5665 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10050 | FWLGNEKIHL | Fibrinogen gamma chain precursor | Urine | 1256.6718 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10051 | LRVAPEEHPVL | "Actin, cytoplasmic 1" | Urine | 1259.714 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10052 | YQQHPGKAPKL | Ig lambda chain V-II region BUR | Urine | 1266.6848 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10053 | SSSERAHQVLR | Vitamin K-dependent protein C | Urine | 1269.6578 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10054 | FKVSFLSALEE | Apolipoprotein A-I | Urine | 1269.6725 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10055 | PENFRLLGNVL | Hemoglobin subunit beta | Urine | 1271.7212 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10056 | SFSKDWSFYL | Beta-2-microglobulin | Urine | 1279.601 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10057 | FVHARTPHAED | Cadherin-13 | Urine | 1279.6016 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10058 | PVSLSQGQPSRQ | Meprin A subunit alpha | Urine | 1283.6579 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10059 | YQQKPGQAPRL | Ig kappa chain V-III region NG9 (Fragment) | Urine | 1285.6882 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10060 | FDFGDDPSDKF | Fibrinogen gamma chain precursor | Urine | 1289.5288 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10061 | LAWYQQKPGQA | Ig kappa chain V-III region NG9 (Fragment) | Urine | 1289.6574 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10062 | GTLSGIGTLDGFR | Fibrinogen alpha chain | Urine | 1293.6832 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10063 | DRVYIHPFHL | Angiotensinogen | Urine | 1296.6753 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10064 | TYVPKEFNAET | Serum albumin precursor | Urine | 1298.6345 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10065 | LRTHLAPYSDE | Apolipoprotein A-I | Urine | 1301.6382 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10066 | YSIITPNILRL | Complement C3 | Urine | 1302.7755 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10067 | YGRAPQLRETL | Protein AMBP | Urine | 1303.7053 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10068 | ITIVNRDGTRY | CD44 antigen | Urine | 1307.6912 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10069 | VVENGESSQGRF | Uromodulin | Urine | 1308.6102 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10070 | LVVYPWTQRF | Hemoglobin subunit beta | Urine | 1308.6826 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10071 | VHLTPEEKSAVT | Hemoglobin subunit beta | Urine | 1310.7355 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10072 | KPVPDLVPGNFK | Fibrinogen alpha chain | Urine | 1310.7476 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10073 | FKPLVEEPQNL | Serum albumin precursor | Urine | 1313.6999 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10074 | RHSASQDGQDTI | Filaggrin | Urine | 1314.6069 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10075 | PWLKKIMDRM | Protein AMBP | Urine | 1317.7008 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10076 | RVSLATVDKTVE | Selenoprotein P | Urine | 1317.7184 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10077 | YSRTQTPRAEL | Prostaglandin-H2 D-isomerase | Urine | 1321.6704 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10078 | ANKADRDQYEL | Serotransferrin precursor | Urine | 1322.6291 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10079 | FKGKWERPFE | Alpha-1-antitrypsin | Urine | 1323.6605 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10080 | RVVAQGVGIPEDS | Protein AMBP | Urine | 1326.6854 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10081 | LKNRFLRPGDD | Prostate-specific antigen | Urine | 1330.7078 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10082 | YGSKEDPQTFY | Serotransferrin precursor | Urine | 1334.5267 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10083 | FVKHSTIFENL | Serotransferrin precursor | Urine | 1334.7147 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10084 | LVKELDRDTVF | Alpha-1-antitrypsin | Urine | 1334.7284 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10085 | LVIKGARDSHAGL | Secreted and transmembrane protein 1 | Urine | 1336.7666 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10086 | QPQGIRPQFTAP | Nuclear receptor coactivator 6 | Urine | 1339.7203 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10087 | SQLQKVPPEWK | Fibrinogen alpha chain | Urine | 1339.7507 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10088 | KVLDAVRGSPAIN | Transthyretin | Urine | 1339.7643 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10089 | YSYRSPHWGST | Prostaglandin-H2 D-isomerase | Urine | 1340.5888 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10090 | PTGAPLDCAAAPGAH | Uncharacterized protein C17orf63 | Urine | 1348.5949 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10091 | FQVRANSAGATRA | Gelsolin | Urine | 1348.7012 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10092 | ILRGDFSSANNR | Fibrinogen alpha chain | Urine | 1349.6919 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10093 | SGEGDFLAEGGGVR | Fibrinogen alpha chain | Urine | 1350.6273 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10094 | PGLPGTTTSSSSSSS | Lysine-specific demethylase 6B | Urine | 1352.6135 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10095 | EVDETYVPKEF | Serum albumin precursor | Urine | 1355.5841 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10096 | WGKVNVDEVGGEA | Hemoglobin subunit beta | Urine | 1359.605 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10097 | AAHLPAEFTPAVH | Hemoglobin subunit alpha | Urine | 1360.7005 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10098 | DAKGSFPWQAKM | Haptoglobin | Urine | 1365.6454 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10099 | TPLGPKWPEPVF | Mannan-binding lectin serine protease 2 | Urine | 1367.7313 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10100 | YHKYSLIKGNF | Protein S100-A8 | Urine | 1369.7184 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10101 | VWKSHKWDRE | Hemopexin | Urine | 1370.6835 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10102 | LRKGANINEKTK | Tankyrase-2 | Urine | 1371.746 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10103 | DVNDEKNWGLSV | Alpha-1-acid glycoprotein 1 | Urine | 1375.6283 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10104 | FDTASTGKTFPGF | Fibrinogen alpha chain | Urine | 1375.6326 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10105 | VTGQYEREKAGF | Inter-alpha-trypsin inhibitor heavy chain H4 | Urine | 1384.6775 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10106 | FVNWIDSIIQR | Leukocyte elastase | Urine | 1390.75 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10107 | DGVPGKDGPRGPTGP | Collagen alpha-1(III) chain | Urine | 1406.6719 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10108 | RAGDALRLAAEYC | C2 calcium-dependent domain-containing protein 4B | Urine | 1408.645 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10109 | VSLGSPSGEVSHPR | Alpha-2-HS-glycoprotein | Urine | 1408.7185 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10110 | VFAPANALPARSEA | Phosphoinositide-3-kinase-interacting protein 1 | Urine | 1413.7387 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10111 | LRTHLAPYSDEL | Apolipoprotein A-I | Urine | 1414.719 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10112 | TVDKSRWQQGNV | Ig gamma-1 chain C region | Urine | 1417.7109 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10113 | TANDSGPRRYTIA | Transthyretin | Urine | 1421.7142 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10114 | KQSKTLFTNPIF | Ligand-dependent nuclear receptor-interacting factor 1 | Urine | 1423.74 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10115 | VIDQSRVLNLGPI | Uromodulin | Urine | 1423.811 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10116 | LASVSTVLTSKYR | Hemoglobin subunit alpha | Urine | 1424.8133 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10117 | GPLGPISGVGGGGLGSGS | WD repeat-containing protein 81 | Urine | 1425.6963 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10118 | RKYLKYSKNIL | Zinc-alpha-2-glycoprotein | Urine | 1425.8143 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10119 | QVSHSFPHPLYD | Prostate-specific antigen | Urine | 1426.6566 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10120 | VNVDEVGGEALGRL | Hemoglobin subunit beta | Urine | 1427.7106 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10121 | GKVGAHAGEYGAEAL | Hemoglobin subunit alpha | Urine | 1429.7096 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10122 | HAHKLRVDPVNF | Hemoglobin subunit alpha | Urine | 1432.7829 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10123 | VSVQPNFQQDKF | Prostaglandin-H2 D-isomerase | Urine | 1436.6688 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10124 | GPRGMPGERGRLGP | Collagen alpha-2(V) chain | Urine | 1436.6914 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10125 | ISKAKGQPREPQV | Ig gamma-1 chain C region | Urine | 1437.7953 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10126 | VTINQSLLAPLRL | "Keratin, type II cytoskeletal 7" | Urine | 1437.8818 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10127 | VKVLDAVRGSPAIN | Transthyretin | Urine | 1438.8388 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10128 | VKRAQRQVVAGLN | Kininogen-1 | Urine | 1438.8527 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10129 | TVLHQDWLNGKE | Ig gamma-1 chain C region | Urine | 1439.6857 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10130 | WLNPDPSQKQNL | Osteopontin | Urine | 1439.7194 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10131 | SKHVEDVPAFQAL | Zinc-alpha-2-glycoprotein | Urine | 1440.7117 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10132 | PSRPPGLPGTTTSSS | Lysine-specific demethylase 6B | Urine | 1441.6646 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10133 | SRVPLGPSAMQNCS | Kinesin-like protein KIF18B | Urine | 1446.6596 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10134 | PGLARQAPKPRKQ | Dermcidin | Urine | 1446.8751 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10135 | DGRNFPPGQGIFSG | B-cell CLL/lymphoma 9 protein | Urine | 1448.7088 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10136 | VVAGVANALAHKYH | Hemoglobin subunit beta | Urine | 1449.7992 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10137 | YEYARRHPDYS | Serum albumin precursor | Urine | 1456.6268 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10138 | VTGAEQSEPGAKGPE | Protein FAM123B | Urine | 1456.6742 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10139 | LQQCPFEDHVKL | Serum albumin precursor | Urine | 1456.7212 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10140 | VLKGDGPVQGIINF | Superoxide dismutase [Cu-Zn] | Urine | 1456.8228 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10141 | RADGTVNQIEGEAT | Apolipoprotein D | Urine | 1460.6754 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10142 | HEALHNHYTQKS | Ig gamma-1 chain C region | Urine | 1464.6756 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10143 | DSGEGDFLAEGGGVR | Fibrinogen alpha chain | Urine | 1465.6552 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10144 | ISRDWHGVPGQVD | Vitronectin | Urine | 1465.717 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10145 | ISKTKGQPREPQV | Ig gamma-2 chain C region | Urine | 1467.8058 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10146 | DQSRVLNLGPITR | Uromodulin | Urine | 1468.7924 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10147 | RQKALSNAANLQR | "Spectrin alpha chain, erythrocyte" | Urine | 1469.8287 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10148 | WGKVNVDEVGGEAL | Hemoglobin subunit beta | Urine | 1472.7381 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10149 | FRVVAQGVGIPEDS | Protein AMBP | Urine | 1473.7144 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10150 | SSVQESQVAQQARG | Apolipoprotein C-III | Urine | 1474.7313 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10151 | APREPAIHSEGQW | Lysosomal alpha-glucosidase | Urine | 1477.7007 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10152 | FQKRLHPYKDF | Prostatic acid phosphatase | Urine | 1478.7719 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10153 | QIKSVPLPTLKMQ | TOX high mobility group box family member 4 | Urine | 1482.8645 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10154 | VWKSHKWDREL | Hemopexin | Urine | 1483.738 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10155 | VSHEDPEVQFNW | Ig gamma-2 chain C region | Urine | 1486.7042 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10156 | SDGLAHLDNLKGTF | Hemoglobin subunit beta | Urine | 1487.752 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10157 | WGSPAASDDGRRTL | Inter-alpha-trypsin inhibitor heavy chain H4 | Urine | 1488.7096 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10158 | FQLFSSPHGKDLL | Serotransferrin precursor | Urine | 1488.7807 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10159 | YESDVMGRGHARL | Alpha-2-macroglobulin | Urine | 1490.7043 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10160 | ITKQKWEAEPVY | Zinc-alpha-2-glycoprotein | Urine | 1491.78 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10161 | PEPAKSAPAPKKGSK | Histone H2B type 1-K | Urine | 1492.8533 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10162 | AHHFGKEFTPPVQ | Hemoglobin subunit beta | Urine | 1494.7507 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10163 | VHLTPEEKSAVTAL | Hemoglobin subunit beta | Urine | 1494.8147 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10164 | VVVNTLGKRAPAFE | Polymeric immunoglobulin receptor | Urine | 1500.84 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10165 | YSYRSPHWGSTY | Prostaglandin-H2 D-isomerase | Urine | 1503.638 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10166 | YSRHPAENGKSNF | Beta-2-microglobulin | Urine | 1506.6618 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10167 | YRENMHRYPNQ | Major prion protein | Urine | 1507.7161 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10168 | TKKFSRHHGPTIT | Protein AMBP | Urine | 1509.8135 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10169 | SVIDQSRVLNLGPI | Uromodulin | Urine | 1510.8126 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10170 | KDPAQFRDPGALAQ | Proline-rich protein 30 | Urine | 1513.7875 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10171 | RRLDYQEGPPGVE | Inter-alpha-trypsin inhibitor heavy chain H4 | Urine | 1515.7416 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10172 | MENGKIKVLNQEL | Apolipoprotein D | Urine | 1515.7608 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10173 | WKQDSQLQKARE | Zinc-alpha-2-glycoprotein | Urine | 1516.7791 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10174 | LVRYTKKVPQVST | Serum albumin precursor | Urine | 1518.886 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10175 | GQLGITKVFSNGADL | Alpha-1-antitrypsin | Urine | 1519.8051 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10176 | LVKHKPKATKEQL | Serum albumin precursor | Urine | 1519.9039 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10177 | SQLQKVPPEWKAL | Fibrinogen alpha chain | Urine | 1523.8701 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10178 | VIDQSRVLNLGPIT | Uromodulin | Urine | 1524.8219 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10179 | QRAISRRVQEAAAA | Alanine and arginine-rich domain-containing protein | Urine | 1526.8346 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10180 | IEVDGRVYHVGLGD | Extracellular sulfatase Sulf-2 | Urine | 1528.7822 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10181 | ADSGEGDFLAEGGGVR | Fibrinogen alpha chain | Urine | 1536.7024 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10182 | ISRDWHGVPGQVDA | Vitronectin | Urine | 1536.7555 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10183 | VKVLDAVRGSPAINV | Transthyretin | Urine | 1537.8637 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10184 | DAHKSEVAHRFKD | Serum albumin precursor | Urine | 1539.7496 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10185 | TWLNPDPSQKQNL | Osteopontin | Urine | 1540.7642 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10186 | SSHIANVERVPFDA | Gelsolin | Urine | 1541.7638 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10187 | ISRAQLVPLPPSTY | Alpha-2-HS-glycoprotein | Urine | 1541.8717 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10188 | AWYQQKPGQAPRL | Ig kappa chain V-III region NG9 (Fragment) | Urine | 1542.7883 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10189 | VAWKADSSPVKAGVE | Ig lambda chain C regions | Urine | 1543.8056 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10190 | INEQWLLTTAKNL | Haptoglobin | Urine | 1543.8459 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10191 | HSARPGAPPPQPLDL | Basement membrane-specific heparan sulfate proteoglycan core protein | Urine | 1552.8021 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10192 | SVVCLLNNFYPRE | Ig kappa chain C region | Urine | 1553.7606 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10193 | YEYARRHPDYSV | Serum albumin precursor | Urine | 1555.7054 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10194 | AGPAPSTVPSSTSKDR | Serine/threonine-protein kinase WNK1 | Urine | 1557.7909 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10195 | SVTEQDSKDSTYSL | Ig kappa chain C region | Urine | 1559.6917 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10196 | LRLPEKVPSAPPQE | Roundabout homolog 4 | Urine | 1560.8674 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10197 | HAHKLRVDPVNFK | Hemoglobin subunit alpha | Urine | 1560.8761 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10198 | ETLPPDLLRGPLQL | Leucine-rich alpha-2-glycoprotein | Urine | 1561.8906 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10199 | ITHRIHWESASLL | Complement C3 | Urine | 1562.8365 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10200 | TVDKSRWQQGNVF | Ig gamma-1 chain C region | Urine | 1564.7625 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10201 | AHHFGKEFTPPVQA | Hemoglobin subunit beta | Urine | 1565.714 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10202 | FTLTISRLEPEDF | Ig kappa chain V-III region NG9 (Fragment) | Urine | 1567.7988 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10203 | GSVIDQSRVLNLGPI | Uromodulin | Urine | 1567.8415 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10204 | YGSKEDPQTFYYA | Serotransferrin precursor | Urine | 1568.7245 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10205 | DEPPQSPWDRVKD | Apolipoprotein A-I | Urine | 1568.7118 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10206 | AARLEALKENGGARL | Apolipoprotein A-I | Urine | 1568.8862 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10207 | AEYHAKATEHLSTL | Apolipoprotein A-I | Urine | 1570.7897 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10208 | EPNVLLLDAGDQYQ | 5'-nucleotidase | Urine | 1574.7159 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10209 | YLAPNNLKPVVAEF | Serotransferrin precursor | Urine | 1574.8553 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10210 | LQQQLELLEEDSM | Coiled-coil domain-containing protein 141 | Urine | 1575.7059 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10211 | AIQTRGGPEKHEVTG | Insulin-like growth factor-binding protein 7 | Urine | 1579.8073 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10212 | QPAGKAEGIREPKVT | Putative ribosomal RNA methyltransferase NOP2 | Urine | 1580.8097 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10213 | IDQSRVLNLGPITR | Uromodulin | Urine | 1581.8746 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10214 | KVAALSAKRAGELDR | Coiled-coil and C2 domain-containing protein 1B | Urine | 1584.8641 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10215 | LSFPTTKTYFPHF | Hemoglobin subunit alpha | Urine | 1585.8043 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10216 | RVVAQGVGIPEDSIF | Protein AMBP | Urine | 1586.8559 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10217 | FRVVAQGVGIPEDSI | Protein AMBP | Urine | 1586.8407 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10218 | ADKPETTKEQLGEF | Alpha-1-acid glycoprotein 1 | Urine | 1592.7546 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10219 | DRVPTPQAIRAAQGL | Peptidoglycan recognition protein 1 | Urine | 1592.8583 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10220 | KAVSFKSQVVAGTNY | Cystatin-B | Urine | 1598.852 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10221 | VQELHQGGRRYMM | Lysosomal alpha-glucosidase | Urine | 1604.7658 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10222 | WYTRDRLVPGPVF | Vesicular integral-membrane protein VIP36 | Urine | 1605.8479 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10223 | LAHHFGKEFTPPVQ | Hemoglobin subunit beta | Urine | 1607.812 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10224 | KVGPEADKYRLTYA | Fibrinogen gamma chain precursor | Urine | 1610.854 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10225 | SVIDQSRVLNLGPIT | Uromodulin | Urine | 1611.8874 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10226 | VEVTGQYEREKAGF | Inter-alpha-trypsin inhibitor heavy chain H4 | Urine | 1612.7779 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10227 | GKVNVDEVGGEALGRL | Hemoglobin subunit beta | Urine | 1612.8639 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10228 | VGGGEQPPPAPAPRRE | Xylosyltransferase 1 | Urine | 1614.8082 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10229 | YLQQCPFEDHVKL | Serum albumin precursor | Urine | 1619.7803 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10230 | HVDPENFRLLGNVL | Hemoglobin subunit beta | Urine | 1622.8663 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10231 | LTKKFSRHHGPTIT | Protein AMBP | Urine | 1622.9102 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10232 | YPGKIDVHWTRAGE | Zinc-alpha-2-glycoprotein | Urine | 1628.8094 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10233 | EEAPSLRPAPPPISGGG | Fibrinogen beta chain | Urine | 1631.8263 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10234 | AAHLPAEFTPAVHASL | Hemoglobin subunit alpha | Urine | 1631.8469 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10235 | HTDLSGKVFVFPRE | Serum amyloid P-component | Urine | 1631.8474 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10236 | FSDGLAHLDNLKGTF | Hemoglobin subunit beta | Urine | 1634.8167 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10237 | AHHFGKEFTPPVQAA | Hemoglobin subunit beta | Urine | 1636.8197 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10238 | VSLGSPSGEVSHPRKT | Alpha-2-HS-glycoprotein | Urine | 1637.8584 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10239 | LSALEEYTKKLNTQ | Apolipoprotein A-I | Urine | 1637.8575 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10240 | AGSEADHEGTHSTKRG | Fibrinogen alpha chain | Urine | 1639.7628 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10241 | IQTEEKIHGKSQNQ | Semenogelin-2 | Urine | 1639.7827 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10242 | VQVFAPANALPARSEA | Phosphoinositide-3-kinase-interacting protein 1 | Urine | 1640.8592 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10243 | VDETYVPKEFNAET | Serum albumin precursor | Urine | 1641.6866 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10244 | NQAQEHFGKDKSKE | Serotransferrin precursor | Urine | 1645.7843 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10245 | ISERWKNFPSPVDA | Hemopexin | Urine | 1645.8522 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10246 | AYLAPNNLKPVVAEF | Serotransferrin precursor | Urine | 1645.8908 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10247 | EPPEQQEPGERQEP | Integrin alpha-7 | Urine | 1649.7363 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10248 | DAHKSEVAHRFKDL | Serum albumin precursor | Urine | 1652.8514 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10249 | SGSVIDQSRVLNLGPI | Uromodulin | Urine | 1654.9003 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10250 | PFEDHVKLVNEVTE | Serum albumin precursor | Urine | 1655.8301 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10251 | LAWYQQKPGQAPRL | Ig kappa chain V-III region NG9 (Fragment) | Urine | 1655.8952 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10252 | GKVKVGVNGFGRIGRL | Glyceraldehyde-3-phosphate dehydrogenase | Urine | 1656.9544 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10253 | DAPGQYGAYFHDDGF | Basement membrane-specific heparan sulfate proteoglycan core protein | Urine | 1659.6662 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10254 | IYEAGLAPYKLRPVA | Lactotransferrin precursor | Urine | 1660.9298 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10255 | KTISKAKGQPREPQV | Ig gamma-1 chain C region | Urine | 1666.9425 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10256 | GSVIDQSRVLNLGPIT | Uromodulin | Urine | 1668.9135 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10257 | GPETLAPSNTEEVNIT | Zinc finger protein 804A | Urine | 1671.8705 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10258 | VRLSSKEPNQKDDGV | Wings apart-like protein homolog | Urine | 1671.9027 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10259 | KESRAKKFQRQHM | Ribonuclease pancreatic | Urine | 1673.8821 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10260 | HAHKLRVDPVNFKL | Hemoglobin subunit alpha | Urine | 1673.9572 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10261 | LSHEQKGRYKQESS | Semenogelin-2 | Urine | 1676.8286 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10262 | VIDQSRVLNLGPITR | Uromodulin | Urine | 1680.9787 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10263 | DEPPQSPWDRVKDL | Apolipoprotein A-I | Urine | 1681.8205 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10264 | NEVKRAQRQVVAGLN | Kininogen-1 | Urine | 1681.9347 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10265 | NKEIPAWVPFDPAAQ | Zinc-alpha-2-glycoprotein | Urine | 1682.8493 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10266 | LRARNDLISDLLSEA | V-type proton ATPase subunit E 2 | Urine | 1685.8995 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10267 | FKVGPEADKYRLTY | Fibrinogen gamma chain precursor | Urine | 1686.8834 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10268 | QGLGSDHELMLRCTK | Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 | Urine | 1687.7573 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10269 | RVVAQGVGIPEDSIFT | Protein AMBP | Urine | 1687.8653 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10270 | PRISVNNVLPVFDNL | Cathepsin D | Urine | 1696.9367 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10271 | KTISKTKGQPREPQV | Ig gamma-2 chain C region | Urine | 1696.9538 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10272 | VLAHHFGKEFTPPVQ | Hemoglobin subunit beta | Urine | 1706.8938 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10273 | AALKKYNSQNQSNNQ | Kininogen-1 | Urine | 1707.8399 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10274 | DAHKSEVAHRFKDLG | Serum albumin precursor | Urine | 1709.8666 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10275 | YHLIQNWPHYRSP | Peptidoglycan recognition protein 1 | Urine | 1710.846 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10276 | VQVFAPANALPARSEAA | Phosphoinositide-3-kinase-interacting protein 1 | Urine | 1711.8959 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10277 | VRYTKKVPQVSTPTL | Serum albumin precursor | Urine | 1717.0035 | MALDI-TOF | Muscle-invasive bladder cancer | Upregulated with 2.26 fold change in muscle invasive bladder cancer vs non invasive bladder cancer and non cancer samples | 21805675 |
| CancerPDF_ID10278 | YNYRHGGRQGQIIY | Gelsolin | Urine | 1724.845 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10279 | GKVNVDEVGGEALGRLL | Hemoglobin subunit beta | Urine | 1725.9539 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10280 | FKDSAHGFLKVPPRM | Serotransferrin precursor | Urine | 1729.907 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10281 | VDISQDNALRDEMRA | SH3 domain-binding glutamic acid-rich-like protein 3 | Urine | 1732.8274 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10282 | FLSFPTTKTYFPHF | Hemoglobin subunit alpha | Urine | 1732.8911 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10283 | FRVVAQGVGIPEDSIF | Protein AMBP | Urine | 1733.946 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10284 | EPPEQQEPGERQEPS | Integrin alpha-7 | Urine | 1736.7631 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10285 | VVSLGSPSGEVSHPRKT | Alpha-2-HS-glycoprotein | Urine | 1736.9297 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10286 | DDQSAETHSHKQSRL | Osteopontin | Urine | 1738.7901 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10287 | SRDGWQLQVQGGVAQL | Secreted and transmembrane protein 1 | Urine | 1741.8727 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10288 | GGPGVGRAAGRGVPAGVPIP | Small nuclear ribonucleoprotein-associated protein N | Urine | 1742.0366 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10289 | LNPDPAEGPKPRPAVW | Roundabout homolog 4 | Urine | 1743.8914 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10290 | WKQDSQLQKAREDI | Zinc-alpha-2-glycoprotein | Urine | 1744.9057 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10291 | LAAHLPAEFTPAVHASL | Hemoglobin subunit alpha | Urine | 1744.9346 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10292 | SDLHAHKLRVDPVNF | Hemoglobin subunit alpha | Urine | 1747.9214 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10293 | VELVKHKPKATKEQL | Serum albumin precursor | Urine | 1748.0332 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10294 | LAHHFGKEFTPPVQAA | Hemoglobin subunit beta | Urine | 1749.9175 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10295 | QRGVGRGAGGGEAGACRPP | Mitoferrin-2 | Urine | 1752.8132 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10296 | ALHNHYTQKSLSLSPG | Ig gamma-1 chain C region | Urine | 1752.8875 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10297 | YADKPETTKEQLGEF | Alpha-1-acid glycoprotein 1 | Urine | 1755.8646 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10298 | SGSVIDQSRVLNLGPIT | Uromodulin | Urine | 1755.975 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10299 | FKVGPEADKYRLTYA | Fibrinogen gamma chain precursor | Urine | 1757.9242 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10300 | LNQAQEHFGKDKSKE | Serotransferrin precursor | Urine | 1758.8699 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10301 | GHGHEQQHGLGHGHKF | Kininogen-1 | Urine | 1762.8371 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10302 | GGAGGPGGAGAGAAAGQLDAQVG | Regulator of nonsense transcripts 1 | Urine | 1766.8079 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10303 | LKNGERIEKVEHSDL | Beta-2-microglobulin | Urine | 1766.9436 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10304 | SEKAKPALEDLRQGLL | Apolipoprotein A-I | Urine | 1767.9961 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10305 | SVIDQSRVLNLGPITR | Uromodulin | Urine | 1767.9996 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10306 | EAGSEADHEGTHSTKRG | Fibrinogen alpha chain | Urine | 1768.7798 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10307 | AQYQKDAPDHQELNL | Complement C3 | Urine | 1769.8455 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10308 | EVQVFAPANALPARSEA | Phosphoinositide-3-kinase-interacting protein 1 | Urine | 1769.902 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10309 | KDLPLDSENVQKDLVG | Centrosome-associated protein 350 | Urine | 1769.9183 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10310 | ISRAQLVPLPPSTYVE | Alpha-2-HS-glycoprotein | Urine | 1769.9784 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10311 | FLTKKFSRHHGPTIT | Protein AMBP | Urine | 1769.9639 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10312 | EVDETYVPKEFNAET | Serum albumin precursor | Urine | 1770.7998 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10313 | FHGQALTNKNYRIDT | Ceruloplasmin | Urine | 1777.8972 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10314 | FVHWQEPRAPLQGTL | Tyrosine-protein kinase receptor UFO | Urine | 1778.9213 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10315 | KDYWSTVKDKFSEF | Apolipoprotein C-III | Urine | 1779.862 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10316 | KLFLGQGLAKDFLDLL | Ras GTPase-activating protein 4 | Urine | 1790.9707 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10317 | AQEHFGKDKSKEFQL | Serotransferrin precursor | Urine | 1791.9021 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10318 | GVVSLGSPSGEVSHPRKT | Alpha-2-HS-glycoprotein | Urine | 1793.9484 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10319 | EEAPSLRPAPPPISGGGY | Fibrinogen beta chain | Urine | 1794.8781 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10320 | LAAPPGHQLHRAHYDL | Alpha-2-HS-glycoprotein | Urine | 1795.974 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10321 | LQQCPFEDHVKLVNE | Serum albumin precursor | Urine | 1798.8659 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10322 | WGKVNVDEVGGEALGRL | Hemoglobin subunit beta | Urine | 1798.948 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10323 | YVSWYQQHPGKAPKL | Ig lambda chain V-II region BUR PE=1 SV=1 | Urine | 1801.9395 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10324 | LIYNQKEGHFPRVTT | Signal-regulatory protein gamma | Urine | 1802.9416 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10325 | ALTQNHHKQYYEGSE | Inter-alpha-trypsin inhibitor heavy chain H1 | Urine | 1804.8264 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10326 | VSVALVLCLNVGVDPPDV | Regulatory-associated protein of mTOR | Urine | 1809.0421 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10327 | VIDQSRVLNLGPITRK | Uromodulin | Urine | 1809.1074 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10328 | PAISSSGPAGSYRPYDEG | Lysosomal alpha-glucosidase | Urine | 1810.807 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10329 | RGKENDTDLDLRYDT | Neurexophilin-1 | Urine | 1810.915 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10330 | LREGRRGSIQVDGEEL | Basement membrane-specific heparan sulfate proteoglycan core protein | Urine | 1813.9403 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10331 | LVVYPWTQRFFESF | Hemoglobin subunit beta | Urine | 1818.9135 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10332 | VSEDPINDGEWHRVTA | Basement membrane-specific heparan sulfate proteoglycan core protein | Urine | 1824.8244 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10333 | ILGGHLDAKGSFPWQAK | Haptoglobin | Urine | 1824.9904 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10334 | GSVIDQSRVLNLGPITR | Uromodulin | Urine | 1825.0741 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10335 | DEAGSEADHEGTHSTKR | Fibrinogen alpha chain | Urine | 1826.7841 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10336 | HEVAQDDHLTQQYNE | Semenogelin-2 | Urine | 1826.789 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10337 | FRYNSKDRKSQPMGL | Zinc-alpha-2-glycoprotein | Urine | 1826.9887 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10338 | LSLQDGCRAILDEVAGLG | Nesprin-1 | Urine | 1829.8799 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10339 | LVRYTKKVPQVSTPTL | Serum albumin precursor | Urine | 1830.0049 | MALDI-TOF | Muscle-invasive bladder cancer | Upregulated in cancer vs normal | 21805675 |
| CancerPDF_ID10340 | FRVVAQGVGIPEDSIFT | Protein AMBP | Urine | 1834.9608 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10341 | AELGGGAGAAAVTSVLGMYAA | Iroquois-class homeodomain protein IRX-1 | Urine | 1836.8531 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10342 | AAELGGGAGAAAVTSVLGMYA | Iroquois-class homeodomain protein IRX-1 | Urine | 1836.8567 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10343 | YMWHLVGHQRNNRQ | Secreted and transmembrane protein 1 | Urine | 1838.8866 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10344 | DAHKSEVAHRFKDLGE | Serum albumin precursor | Urine | 1838.9121 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10345 | LGRHSLFHPEDTGQVF | Prostate-specific antigen | Urine | 1839.9058 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10346 | QSPGASPSQAERLPSDSE | Msx2-interacting protein | Urine | 1842.8918 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10347 | VSWVPPPAENHNGIIRG | Roundabout homolog 4 | Urine | 1842.9449 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10348 | YSQGSKGPGEDFRMATL | Prostaglandin-H2 D-isomerase | Urine | 1843.8586 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10349 | LVVNVPPQIHEKEASSP | Vascular endothelial growth factor receptor 3 | Urine | 1843.9319 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10350 | TTTPSKQSNNKYAASSY | Ig lambda chain C regions | Urine | 1847.9319 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10351 | VLAHHFGKEFTPPVQAA | Hemoglobin subunit beta | Urine | 1848.8949 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10352 | DEPPQSPWDRVKDLAT | Apolipoprotein A-I | Urine | 1853.9034 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10353 | AALKKYNSQNQSNNQF | Kininogen-1 | Urine | 1854.8953 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10354 | VQLQDVPRGQVVKGSVF | Complement C4-A | Urine | 1856.0386 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10355 | VSGRSPGPNVAVNAKGSVY | Basement membrane-specific heparan sulfate proteoglycan core protein | Urine | 1858.9618 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10356 | YVVSIVALNGREESPLL | Fibronectin | Urine | 1859.0217 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10357 | NLNDRLASYLDKVRAL | "Keratin, type I cytoskeletal 19" | Urine | 1861.0229 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10358 | SHEQKGRHQHGSHGGLD | Semenogelin-1 | Urine | 1866.8648 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10359 | YQKVVAGVANALAHKYH | Hemoglobin subunit beta | Urine | 1869.0127 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10360 | RPSGCDAPYGAPSAAPGPAQ | MyoD family inhibitor | Urine | 1869.9142 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10361 | DEAPGQEQRGPEDQDIS | Neutrophil defensin 4 | Urine | 1870.8096 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10362 | AAHLPAEFTPAVHASLDK | Hemoglobin subunit alpha | Urine | 1875.0317 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10363 | KESRAKKFQRQHMDS | Ribonuclease pancreatic | Urine | 1875.9368 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10364 | LLKNGERIEKVEHSDL | Beta-2-microglobulin | Urine | 1880.0366 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10365 | DEAGSEADHEGTHSTKRG | Fibrinogen alpha chain | Urine | 1883.8115 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10366 | ELEPPEQQEPGERQEP | Integrin alpha-7 | Urine | 1891.8512 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10367 | WKQDSQLQKAREDIF | Zinc-alpha-2-glycoprotein | Urine | 1891.9692 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10368 | PHGQKGQHYSGQKGKQQ | Semenogelin-1 | Urine | 1892.9567 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10369 | RREAERRASGAPSAGPEP | Perilipin-1 | Urine | 1893.8712 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10370 | HKSEVAHRFKDLGEEN | Serum albumin precursor | Urine | 1895.9285 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10371 | FKGKWERPFEVKDTE | Alpha-1-antitrypsin | Urine | 1896.0139 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10372 | DHEGTHSTKRGHAKSRP | Fibrinogen alpha chain | Urine | 1900.9488 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10373 | DDQSAETHSHKQSRLY | Osteopontin | Urine | 1901.8467 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10374 | VCVLAHHFGKEFTPPVQ | Hemoglobin subunit beta | Urine | 1908.9705 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10375 | YSKLTVDKSRWQQGNV | Ig gamma-1 chain C region | Urine | 1908.9826 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10376 | LLDEEKAERGSHQGKKS | Centrosome-associated protein 350 | Urine | 1912.0233 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10377 | WGKVNVDEVGGEALGRLL | Hemoglobin subunit beta | Urine | 1912.0233 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10378 | SGSVIDQSRVLNLGPITR | Uromodulin | Urine | 1912.0595 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10379 | FRTQTAPGGQGAPWAEEL | Roundabout homolog 4 | Urine | 1915.9188 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10380 | ATLSELHCDKLHVDPEN | Hemoglobin subunit beta | Urine | 1920.8422 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10381 | FKVGPEADKYRLTYAY | Fibrinogen gamma chain precursor | Urine | 1920.9709 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10382 | IKKGYTQQLAFRQPSSA | Complement C3 | Urine | 1923.0429 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10383 | ENKDGKVNIDDLVKVIE | "LETM1 and EF-hand domain-containing protein 1, mitochondrial" | Urine | 1928.0139 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10384 | YIKVRAGDNKYMHLKV | Cystatin-A | Urine | 1935.0362 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10385 | LTKKFSRHHGPTITAKL | Protein AMBP | Urine | 1935.1239 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10386 | AYQKVVAGVANALAHKYH | Hemoglobin subunit beta | Urine | 1940.0239 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10387 | YGIHKQKEKSRLQGGVL | Prostatic acid phosphatase | Urine | 1941.0835 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10388 | VSWNSGALTSGVHTFPAVL | Ig gamma-1 chain C region | Urine | 1943.0285 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10389 | LLVRYTKKVPQVSTPTL | Serum albumin precursor | Urine | 1943.1669 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10390 | AAAGVQPHSLDLSHNSLRA | Monocyte differentiation antigen CD14 | Urine | 1944.0021 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10391 | VTLAAHLPAEFTPAVHASL | Hemoglobin subunit alpha | Urine | 1945.0508 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10392 | VRYTKKVPQVSTPTLVE | Serum albumin precursor | Urine | 1945.1115 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10393 | VSVQPNFQQDKFLGRW | Prostaglandin-H2 D-isomerase | Urine | 1948.9773 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10394 | YTKVVHYRKWIKDTI | Prostate-specific antigen | Urine | 1950.0765 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10395 | FDTASTGKTFPGFFSPML | Fibrinogen alpha chain | Urine | 1950.9286 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10396 | ILGGHLDAKGSFPWQAKM | Haptoglobin | Urine | 1956.0108 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10397 | VTFKNPLVWVHASPEHV | Inter-alpha-trypsin inhibitor heavy chain H4 | Urine | 1960.0218 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10398 | FAQYLQQCPFEDHVKL | Serum albumin precursor | Urine | 1965.9536 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10399 | AKLHDRNTYEKYLGEE | Serotransferrin precursor | Urine | 1965.9475 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10400 | FRVVAQGVGIPEDSIFTM | Protein AMBP | Urine | 1965.9974 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10401 | AHKSEVAHRFKDLGEEN | Serum albumin precursor | Urine | 1966.9727 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10402 | DAHKSEVAHRFKDLGEE | Serum albumin precursor | Urine | 1967.9657 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10403 | LRTHLAPYSDELRQRL | Apolipoprotein A-I | Urine | 1968.0614 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10404 | TETIEGVDAEDGHGPGEQQ | Complement factor B | Urine | 1968.8631 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10405 | PSDWDSRGKDSYETSQL | Osteopontin | Urine | 1970.8731 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10406 | ADHEGTHSTKRGHAKSRP | Fibrinogen alpha chain | Urine | 1971.9887 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10407 | SGGEGKGGSDGGGSHRKEGEE | CD99 antigen | Urine | 1973.9468 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10408 | AIQTRGGPEKHEVTGWVL | Insulin-like growth factor-binding protein 7 | Urine | 1978.0448 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10409 | ELEPPEQQEPGERQEPS | Integrin alpha-7 | Urine | 1978.958 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10410 | DKLHVDPENFRLLGNVL | Hemoglobin subunit beta | Urine | 1979.0686 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10411 | LSHEQKGRHQHGSHGGLD | Semenogelin-1 | Urine | 1979.9507 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10412 | LAFPGHVFSRSLPEVPET | Basement membrane-specific heparan sulfate proteoglycan core protein | Urine | 1983.0097 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10413 | ALWGKVNVDEVGGEALGRL | Hemoglobin subunit beta | Urine | 1983.061 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10414 | YPGKIDVHWTRAGEVQE | Zinc-alpha-2-glycoprotein | Urine | 1984.9602 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10415 | LLVPRSSTSPDRIFFHL | Alpha-1B-glycoprotein | Urine | 1985.0815 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10416 | DGVSGGEGKGGSDGGGSHRKEG | CD99 antigen | Urine | 1986.8795 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10417 | YINQNLPWGYKHTLNQ | Alpha-2-HS-glycoprotein | Urine | 1988.9979 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10418 | SDLHAHKLRVDPVNFKL | Hemoglobin subunit alpha | Urine | 1989.1011 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10419 | ARNPNLPPETVDSLKNIL | Apolipoprotein D | Urine | 1991.1821 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10420 | LKNGERIEKVEHSDLSF | Beta-2-microglobulin | Urine | 2001.0415 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10421 | AKVQWKVDNALQSGNSQE | Ig kappa chain C region | Urine | 2002.0414 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10422 | AAYQKVVAGVANALAHKYH | Hemoglobin subunit beta | Urine | 2011.0843 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10423 | VAEKALQEYRKKHREE | Clusterin | Urine | 2014.0714 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10424 | AGGSQRTISLGAGDRQVIQT | Myotubularin-related protein 5 | Urine | 2015.1457 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10425 | SDETLPAPEFSPEPESGRA | Alpha-1B-glycoprotein | Urine | 2015.8963 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10426 | SALSDLHAHKLRVDPVNF | Hemoglobin subunit alpha | Urine | 2019.0617 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10427 | DEAGSEADHEGTHSTKRGH | Fibrinogen alpha chain | Urine | 2020.8813 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10428 | AAHLPAEFTPAVHASLDKF | Hemoglobin subunit alpha | Urine | 2022.0399 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10429 | VYDAYLAPNNLKPVVAEF | Serotransferrin precursor | Urine | 2023.0442 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10430 | TSGPGPVKCGGGGGGGGEGRGAPR | Putative histone-lysine N-methyltransferase PRDM6 | Urine | 2024.9347 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10431 | IVNTNVPRASVPDGFLSEL | Macrophage migration inhibitory factor | Urine | 2028.0676 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10432 | SHEQKGRYKQESSESHN | Semenogelin-2 | Urine | 2030.9282 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10433 | NQAQEHFGKDKSKEFQL | Serotransferrin precursor | Urine | 2034.0034 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10434 | ASPPRLPEPQPYPGAPHHS | Collagen alpha-1(XVIII) chain | Urine | 2034.9958 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10435 | LIKKGYTQQLAFRQPSSA | Complement C3 | Urine | 2036.1576 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10436 | SGSVIDQSRVLNLGPITRK | Uromodulin | Urine | 2040.2504 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10437 | HKSEVAHRFKDLGEENF | Serum albumin precursor | Urine | 2043.0109 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10438 | RGGGAGGAGLHFAGHRRREE | Adenomatous polyposis coli protein 2 | Urine | 2047.9476 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10439 | DAAQKTDTSHHDQDHPTF | Alpha-1-antitrypsin | Urine | 2050.89 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10440 | VCVLAHHFGKEFTPPVQAA | Hemoglobin subunit beta | Urine | 2051.0364 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10441 | LVTLAAHLPAEFTPAVHASL | Hemoglobin subunit alpha | Urine | 2058.1277 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10442 | LVRYTKKVPQVSTPTLVE | Serum albumin precursor | Urine | 2058.1925 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10443 | SSLKDYWSTVKDKFSEF | Apolipoprotein C-III | Urine | 2066.9939 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10444 | AALKKYNSQNQSNNQFVL | Kininogen-1 | Urine | 2067.0617 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10445 | ATLSELHCDKLHVDPENF | Hemoglobin subunit beta | Urine | 2067.93 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10446 | LREGETKAVKTVRTPGAAAN | Alpha-1B-glycoprotein | Urine | 2069.1435 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10447 | IKKGYTQQLAFRQPSSAF | Complement C3 | Urine | 2070.0923 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10448 | ADHEGTHSTKRGHAKSRPV | Fibrinogen alpha chain | Urine | 2071.0453 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10449 | VSGGEGKGGSDGGGSHRKEGEE | CD99 antigen | Urine | 2072.9208 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10450 | SEKAKPALEDLRQGLLPVL | Apolipoprotein A-I | Urine | 2077.1948 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10451 | LEYRGYDSAGVAIDGNNHE | Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 2 | Urine | 2079.9005 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10452 | QGQGQGQGQGQGQGRRPGLVS | Mesoderm posterior protein 2 | Urine | 2079.9366 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10453 | DAHKSEVAHRFKDLGEEN | Serum albumin precursor | Urine | 2082.0004 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10454 | AKVQWKVDNALQSGNSQES | Ig kappa chain C region | Urine | 2089.1188 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10455 | LQDFRVVAQGVGIPEDSIF | Protein AMBP | Urine | 2090.0899 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10456 | DEAGSEADHEGTHSTKRGHA | Fibrinogen alpha chain | Urine | 2091.892 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10457 | SYSMEHFRWGKPVGKKR | Pro-opiomelanocortin | Urine | 2093.1404 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10458 | VDLLKNGERIEKVEHSDL | Beta-2-microglobulin | Urine | 2094.1087 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10459 | VKKARVQVVAGKKYFIDF | Kininogen-1 | Urine | 2096.2324 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10460 | SSQGGSLPSEEKGHPQEESE | Secretogranin-1 | Urine | 2098.8914 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10461 | LSDLHAHKLRVDPVNFKL | Hemoglobin subunit alpha | Urine | 2102.1746 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10462 | DGQPGAKGEPGDAGAKGDAGPPGP | Collagen alpha-1(I) chain | Urine | 2102.93 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10463 | LVVYPWTQRFFESFGDL | Hemoglobin subunit beta | Urine | 2104.0387 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10464 | ELEPPEQQEPGERQEPSM | Integrin alpha-7 | Urine | 2109.943 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10465 | AHKSEVAHRFKDLGEENF | Serum albumin precursor | Urine | 2114.0375 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10466 | LLKNGERIEKVEHSDLSF | Beta-2-microglobulin | Urine | 2114.1109 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10467 | DEPPQSPWDRVKDLATVY | Apolipoprotein A-I | Urine | 2116.0234 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10468 | LNNFYPREAKVQWKVDN | Ig kappa chain C region | Urine | 2121.0696 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10469 | ASPPRLPEPQPYPGAPHHSS | Collagen alpha-1(XVIII) chain | Urine | 2122.0257 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10470 | NEVGTGLGPTLEFYALVSQE | Probable E3 ubiquitin-protein ligase TRIP12 | Urine | 2123.9587 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10471 | LQQCPFEDHVKLVNEVTE | Serum albumin precursor | Urine | 2128.0182 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10472 | IVIIEQEDDSDRHLAQHL | Semenogelin-1 | Urine | 2131.0626 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10473 | PGAKGEDGKDGSPGEPGANGLPGA | Collagen alpha-1(III) chain | Urine | 2134.9569 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10474 | AAHLPAEFTPAVHASLDKFL | Hemoglobin subunit alpha | Urine | 2135.1244 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10475 | AGGGAGGGGAGGGGSPPGGWAVARLEG | Forkhead box protein K2 | Urine | 2136.9535 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10476 | GGAGLTGGGTAAGVAGAAAGVAGAAVAGP | Ras GTPase-activating protein 1 | Urine | 2137.0737 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10477 | TQFSDSTVQSGGSHTALGDRS | Protein HEG homolog 1 | Urine | 2137.9761 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10478 | KQGGGGGGGSVPGIERMGPGIDR | Heterogeneous nuclear ribonucleoprotein M | Urine | 2139.0212 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10479 | ERRLNYGGKSTQKDVSQSS | Semenogelin-2 | Urine | 2140.0323 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10480 | LSHEQKGRYKQESSESHN | Semenogelin-2 | Urine | 2144.007 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10481 | LNQAQEHFGKDKSKEFQL | Serotransferrin precursor | Urine | 2147.0855 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10482 | AQVSVQPNFQQDKFLGRW | Prostaglandin-H2 D-isomerase | Urine | 2148.0733 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10483 | LRQAQEKFGKDKSPKFQL | Lactotransferrin precursor | Urine | 2148.1724 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10484 | IAFAQYLQQCPFEDHVKL | Serum albumin precursor | Urine | 2150.0682 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10485 | YMWHLVGHQRNNRQVTL | Secreted and transmembrane protein 1 | Urine | 2152.0971 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10486 | AVGEYNKASNDMYHSRALQ | Cystatin-C | Urine | 2153.9887 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10487 | HVDGPPPRPQLRATWSGAVL | Alpha-1B-glycoprotein | Urine | 2154.1407 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10488 | NAPSDWDSRGKDSYETSQL | Osteopontin | Urine | 2155.956 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10489 | YTLFHQAHVAGETVARPLF | Lysosomal alpha-glucosidase | Urine | 2157.1061 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10490 | DKKREEAPSLRPAPPPISGGG | Fibrinogen beta chain | Urine | 2159.0898 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10491 | ADEAGSEADHEGTHSTKRGHA | Fibrinogen alpha chain | Urine | 2162.9476 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10492 | LLRREGDHEFLEVPEAQE | Alpha-1B-glycoprotein | Urine | 2167.0715 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10493 | LRVLRAQPVQVAEGSEPDGF | Gelsolin | Urine | 2168.1372 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10494 | LSAEGGGSAGGGGGAGAGVASGPELLD | SH3 and multiple ankyrin repeat domains protein 1 | Urine | 2170.9832 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10495 | LLVRYTKKVPQVSTPTLVE | Serum albumin precursor | Urine | 2171.2803 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10496 | YSRTQTPRAELKEKFTAF | Prostaglandin-H2 D-isomerase | Urine | 2173.1237 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10497 | YSMRKMSMKIRPFFPQQ | Fibrinogen beta chain | Urine | 2175.0927 | MALDI-TOF | Muscle-invasive bladder cancer | Upregulated in cancer vs normal | 21805675 |
| CancerPDF_ID10498 | NAFPPGLWRQISPQPSTGLI | Protein FAM111B | Urine | 2179.1037 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10499 | LVKHKPKATKEQLKAVMDD | Serum albumin precursor | Urine | 2179.3232 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10500 | VDLLKNGERIEKVEHSDLS | Beta-2-microglobulin | Urine | 2181.1488 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10501 | ALDKLKEFGNTLEDKAREL | Apolipoprotein C-I | Urine | 2190.1716 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10502 | FKIDNVKKARVQVVAGKKY | Kininogen-1 | Urine | 2191.2944 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10503 | VSGYPKRLEKEVGTPHGIIL | Hemopexin | Urine | 2193.2343 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10504 | HSATRERRLDYQEGPPGVE | Inter-alpha-trypsin inhibitor heavy chain H4 | Urine | 2197.0218 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10505 | YIGSKYKKVVYRQYTDST | Ceruloplasmin | Urine | 2199.1384 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10506 | LDGAKGDAGPAGPKGEPGSPGENGA | Collagen alpha-1(I) chain | Urine | 2206.0017 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10507 | AVETLQAGQDGPGSQVDTLLRG | FLYWCH-type zinc finger-containing protein 1 | Urine | 2212.0302 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10508 | FSSLKDYWSTVKDKFSEF | Apolipoprotein C-III | Urine | 2214.0781 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10509 | KPRLLLFSPSVVHLGVPLSVG | Complement C4-A | Urine | 2215.3122 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10510 | LRTLNQPDSQLQLTTGNGLF | Alpha-1-antitrypsin | Urine | 2216.1533 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10511 | DEAGSEADHEGTHSTKRGHAK | Fibrinogen alpha chain | Urine | 2219.9969 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10512 | SKEQTSVSGAQKGRKQGGSQSS | Semenogelin-1 | Urine | 2222.1067 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10513 | EVDLLKNGERIEKVEHSDL | Beta-2-microglobulin | Urine | 2223.1581 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10514 | LAFPGHVFSRSLPEVPETIE | Basement membrane-specific heparan sulfate proteoglycan core protein | Urine | 2225.1512 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10515 | SKVSREFHSHEFHSHEDM | Osteopontin | Urine | 2225.964 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10516 | DAHKSEVAHRFKDLGEENF | Serum albumin precursor | Urine | 2229.0114 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10517 | KREEAPSLRPAPPPISGGGYR | Fibrinogen beta chain | Urine | 2235.2016 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10518 | HKSEVAHRFKDLGEENFKA | Serum albumin precursor | Urine | 2242.1336 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10519 | LVRGSGEGGPQGNSSAGWAVASPC | G-protein coupled receptor family C group 5 member C | Urine | 2243.9954 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10520 | DGVSGGEGKGGSDGGGSHRKEGEE | CD99 antigen | Urine | 2244.9891 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10521 | FKQETLPSKSNESHDHMDD | Osteopontin | Urine | 2244.9821 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10522 | AVTALWGKVNVDEVGGEALGRL | Hemoglobin subunit beta | Urine | 2254.2099 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10523 | SQFPHGQKGQHYSGQKGKQQ | Semenogelin-1 | Urine | 2255.0999 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10524 | SSLTETIEGVDAEDGHGPGEQQ | Complement factor B | Urine | 2256.0136 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10525 | SALSDLHAHKLRVDPVNFKL | Hemoglobin subunit alpha | Urine | 2260.2508 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10526 | QGQGQGQGQGQGQGQGRRPGLVS | Mesoderm posterior protein 2 | Urine | 2265.0274 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10527 | ERRLNSGEKDVQKGVSKGSIS | Semenogelin-2 | Urine | 2274.2031 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10528 | GEVGAPGSKGEAGPTGPMGAMGPLGP | Collagen alpha-2(V) chain | Urine | 2279.0635 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10529 | AGGGSGGGNGAGGGGAGGAGGGGGGGSRAPPE | Homeobox protein SIX3 | Urine | 2281.9758 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10530 | PEILFNPSDIGIQEMGIPEAI | Actin-related protein 6 | Urine | 2283.0701 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10531 | EEVSGNVSPGTRREYHTEKL | Fibrinogen alpha chain | Urine | 2288.1179 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10532 | AKVQWKVDNALQSGNSQESVT | Ig kappa chain C region | Urine | 2289.136 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10533 | GAVEDVISRNEIQGRSAEEAY | NF-kappa-B-repressing factor | Urine | 2293.0049 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10534 | AAHLPAEFTPAVHASLDKFLAS | Hemoglobin subunit alpha | Urine | 2293.2203 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10535 | LEAIPMSIPPEVKFNKPFVF | Alpha-1-antitrypsin | Urine | 2303.2463 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10536 | VSGSTGQWHSESGSFRPDSPGSG | Fibrinogen alpha chain | Urine | 2305.9893 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10537 | DEAGSEADHEGTHSTKRGHAKS | Fibrinogen alpha chain | Urine | 2307.0304 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10538 | FAQYLQQCPFEDHVKLVNE | Serum albumin precursor | Urine | 2308.0936 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10539 | SEETKENEGFTVTAEGKGQGTL | Complement C3 | Urine | 2312.0743 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10540 | AHKSEVAHRFKDLGEENFKA | Serum albumin precursor | Urine | 2313.1675 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10541 | VAGKSQIQAPNPKQEPWHGEN | Semenogelin-1 | Urine | 2315.1321 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10542 | FLYSKLTVDKSRWQQGNVF | Ig gamma-1 chain C region | Urine | 2316.2025 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10543 | DKKREEAPSLRPAPPPISGGGY | Fibrinogen beta chain | Urine | 2322.2307 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10544 | VDLLKNGERIEKVEHSDLSF | Beta-2-microglobulin | Urine | 2328.1596 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10545 | LKNGERIEKVEHSDLSFSKD | Beta-2-microglobulin | Urine | 2331.1916 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10546 | YTKVVHYRKWIKDTIVANP | Prostate-specific antigen | Urine | 2331.2857 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10547 | VTLAAHLPAEFTPAVHASLDKF | Hemoglobin subunit alpha | Urine | 2335.2281 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10548 | IEVDLLKNGERIEKVEHSDL | Beta-2-microglobulin | Urine | 2336.2268 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10549 | PHGQKGQHYSGQKGKQQTESK | Semenogelin-1 | Urine | 2338.1706 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10550 | SKVSREFHSHEFHSHEDML | Osteopontin | Urine | 2339.0664 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10551 | LSKVSREFHSHEFHSHEDM | Osteopontin | Urine | 2339.0669 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10552 | LSDPEQGVEVTGQYEREKAGF | Inter-alpha-trypsin inhibitor heavy chain H4 | Urine | 2339.1062 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10553 | HAHKLRVDPVNFKLLSHCLL | Hemoglobin subunit alpha | Urine | 2340.3031 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10554 | VAQDDHLTQQYNEDRNPIST | Semenogelin-2 | Urine | 2344.0663 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10555 | DEELGGTPVQSRVVQGKEPAHL | Gelsolin | Urine | 2346.2069 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10556 | VTLDGGFIYEAGLAPYKLRPVA | Lactotransferrin precursor | Urine | 2350.2693 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10557 | GTLSGIGTLDGFRHRHPDEAAF | Fibrinogen alpha chain | Urine | 2354.154 | MALDI-TOF | Muscle-invasive bladder cancer | Upregulated in cancer vs normal | 21805675 |
| CancerPDF_ID10558 | INVHLRAGYIIPLQGPGLTTTE | Lysosomal alpha-glucosidase | Urine | 2363.2925 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10559 | DIQGPTKADTEKWAEGGGHSRE | Secretogranin-1 | Urine | 2369.0907 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10560 | FKQETLPSKSNESHDHMDDM | Osteopontin | Urine | 2376.0173 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10561 | DAGLVYDAYLAPNNLKPVVAEF | Serotransferrin precursor | Urine | 2379.2047 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10562 | LRTHLAPYSDELRQRLAARL | Apolipoprotein A-I | Urine | 2379.3258 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10563 | IVITEHEVAQDDHLTQQYNE | Semenogelin-2 | Urine | 2382.1094 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10564 | VDLFSPEKSKLPGIVAEGRDDL | Antithrombin-III | Urine | 2385.2626 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10565 | ERQPGNQKACFKEEIITHEE | Zinc finger protein 570 | Urine | 2386.0517 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10566 | VAGKSQIQAPNPKQEPWHGENA | Semenogelin-1 | Urine | 2386.1652 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10567 | MIEQNTKSPLFMGKVVNPTQK | Alpha-1-antitrypsin | Urine | 2390.2117 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10568 | PHGQKGQHYSGQKGKQQTESKG | Semenogelin-1 | Urine | 2395.182 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10569 | LRREGDHEFLEVPEAQEDVE | Alpha-1B-glycoprotein | Urine | 2397.1264 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10570 | FSQFPHGQKGQHYSGQKGKQQ | Semenogelin-1 | Urine | 2402.1471 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10571 | DDILASPPRLPEPQPYPGAPHH | Collagen alpha-1(XVIII) chain | Urine | 2404.1687 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10572 | ELVKHKPKATKEQLKAVMDD | Serum albumin precursor | Urine | 2407.3166 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10573 | VSGSTGQWHSESGSFRPDSPGSGN | Fibrinogen alpha chain | Urine | 2420.0441 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10574 | VSVQPNFQQDKFLGRWFSAGL | Prostaglandin-H2 D-isomerase | Urine | 2424.244 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10575 | DAHKSEVAHRFKDLGEENFKA | Serum albumin precursor | Urine | 2428.2029 | MALDI-TOF | Muscle-invasive bladder cancer | Upregulated in cancer vs normal | 21805675 |
| CancerPDF_ID10576 | GSTGSWNSGSSGTGSTGNQNPGSPRP | Fibrinogen alpha chain | Urine | 2434.0611 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10577 | APEAQVSVQPNFQQDKFLGRW | Prostaglandin-H2 D-isomerase | Urine | 2445.2213 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10578 | NGFKSHALQLNNRQIRGLEEE | Complement C4-A | Urine | 2453.2529 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10579 | SALTSDNHGATYAFSGTHYWRL | Hemopexin | Urine | 2455.1245 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10580 | EVDLLKNGERIEKVEHSDLSF | Beta-2-microglobulin | Urine | 2457.2621 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10581 | VRVTASDPLDTLGSEGALSPGGVASL | Complement C4-A | Urine | 2469.2767 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10582 | VLSPADKTNVKAAWGKVGAHAGEY | Hemoglobin subunit alpha | Urine | 2469.2832 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10583 | IYTGLSKHVEDVPAFQALGSLND | Zinc-alpha-2-glycoprotein | Urine | 2474.2609 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10584 | AAHLPAEFTPAVHASLDKFLASVS | Hemoglobin subunit alpha | Urine | 2479.2756 | MALDI-TOF | Muscle-invasive bladder cancer | Upregulated in cancer vs normal | 21805675 |
| CancerPDF_ID10585 | PHGQKGQHYSGQKGKQQTESKGS | Semenogelin-1 | Urine | 2482.2283 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10586 | VSGGEGKGGSDGGGSHRKEGEEADAPG | CD99 antigen | Urine | 2484.1098 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10587 | IAVEWESNGQPENNYKTTPPVL | Ig gamma-1 chain C region | Urine | 2486.2068 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10588 | AQYLQQCPFEDHVKLVNEVTE | Serum albumin precursor | Urine | 2490.1956 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10589 | IAFAQYLQQCPFEDHVKLVNE | Serum albumin precursor | Urine | 2492.2137 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10590 | VREDRGGRRVHRFQSPAGTEAL | Alpha-1B-glycoprotein | Urine | 2494.3016 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10591 | LMIEQNTKSPLFMGKVVNPTQK | Alpha-1-antitrypsin | Urine | 2503.3475 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10592 | LLRREGDHEFLEVPEAQEDVE | Alpha-1B-glycoprotein | Urine | 2510.2191 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10593 | FLSSLTETIEGVDAEDGHGPGEQQ | Complement factor B | Urine | 2516.1478 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10594 | YFAGGDAGDAFDGFDFGDDPSDKF | Fibrinogen gamma chain precursor | Urine | 2533.0019 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10595 | DAHKSEVAHRFKDLGEENFKAL | Serum albumin precursor | Urine | 2541.2328 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10596 | YPREAKVQWKVDNALQSGNSQE | Ig kappa chain C region | Urine | 2547.2324 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10597 | SELHCDKLHVDPENFRLLGNVL | Hemoglobin subunit beta | Urine | 2548.2929 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10598 | FAVYDQSATALHFLGRVANPLSTA | Angiotensinogen | Urine | 2549.3048 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10599 | DEAGSEADHEGTHSTKRGHAKSRP | Fibrinogen alpha chain | Urine | 2560.1784 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10600 | HKSEVAHRFKDLGEENFKALVL | Serum albumin precursor | Urine | 2567.3749 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10601 | FKKNWIQYKEGFGHLSPTGTTE | Fibrinogen gamma chain precursor | Urine | 2568.2859 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10602 | IEVDLLKNGERIEKVEHSDLSF | Beta-2-microglobulin | Urine | 2570.3442 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10603 | IQRTPKIQVYSRHPAENGKSNF | Beta-2-microglobulin | Urine | 2570.3511 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10604 | SQFPHGQKGQHYSGQKGKQQTES | Semenogelin-1 | Urine | 2572.2139 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10605 | EDPQGDAAQKTDTSHHDQDHPTF | Alpha-1-antitrypsin | Urine | 2577.0808 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10606 | DVSSALDKLKEFGNTLEDKAREL | Apolipoprotein C-I | Urine | 2578.3322 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10607 | LRSEETKENEGFTVTAEGKGQGTL | Complement C3 | Urine | 2581.2753 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10608 | TPCKQPRCGGGGCGGGGGGGGGGGPAGGGASPP | F-box/LRR-repeat protein 17 | Urine | 2582.1579 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10609 | AFLSSLTETIEGVDAEDGHGPGEQQ | Complement factor B | Urine | 2587.1776 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10610 | AYFAGGDAGDAFDGFDFGDDPSDKF | Fibrinogen gamma chain precursor | Urine | 2604.0364 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10611 | LKNGERIEKVEHSDLSFSKDWS | Beta-2-microglobulin | Urine | 2604.2965 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10612 | VTLAAHLPAEFTPAVHASLDKFLAS | Hemoglobin subunit alpha | Urine | 2606.3727 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10613 | HEVAQDDHLTQQYNEDRNPIST | Semenogelin-2 | Urine | 2610.2222 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10614 | AQVSVQPNFQQDKFLGRWFSAGL | Prostaglandin-H2 D-isomerase | Urine | 2623.3379 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10615 | HTVHFHGHSFQYKHRGVYSSDV | Ceruloplasmin | Urine | 2625.2474 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10616 | KDFLKKHNLNPARKYFPQWEA | Pepsin A | Urine | 2630.3959 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10617 | FAQYLQQCPFEDHVKLVNEVTE | Serum albumin precursor | Urine | 2637.2685 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10618 | AHKSEVAHRFKDLGEENFKALVL | Serum albumin precursor | Urine | 2638.407 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10619 | IQTEEQIHGKSQNQVRIPSQAQE | Semenogelin-2 | Urine | 2648.3281 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10620 | SDLHAHKLRVDPVNFKLLSHCLL | Hemoglobin subunit alpha | Urine | 2655.4468 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10621 | VDLLKNGERIEKVEHSDLSFSKD | Beta-2-microglobulin | Urine | 2658.3742 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10622 | AQLDEELGGTPVQSRVVQGKEPAHL | Gelsolin | Urine | 2658.381 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10623 | DEAGSEADHEGTHSTKRGHAKSRPV | Fibrinogen alpha chain | Urine | 2659.2521 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10624 | EAHDAQGDVPVTVTVHDFPGKKLVL | Complement C3 | Urine | 2672.4004 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10625 | ALVREDRGGRRVHRFQSPAGTEAL | Alpha-1B-glycoprotein | Urine | 2678.4265 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10626 | IWELLNQAQEHFGKDKSKEFQL | Serotransferrin precursor | Urine | 2688.382 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10627 | SPADKTNVKAAWGKVGAHAGEYGAEAL | Hemoglobin subunit alpha | Urine | 2698.3394 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10628 | LSHEQKGRYKQESSESHNIVITE | Semenogelin-2 | Urine | 2699.3305 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10629 | EALKENGGARLAEYHAKATEHLSTL | Apolipoprotein A-I | Urine | 2709.3978 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10630 | FKIDNVKKARVQVVAGKKYFIDF | Kininogen-1 | Urine | 2713.547 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10631 | VLSPADKTNVKAAWGKVGAHAGEYGAE | Hemoglobin subunit alpha | Urine | 2726.3911 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10632 | QAQSKGNPEQTPVLKPEEEAPAPEVG | Vitronectin | Urine | 2730.3391 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10633 | GSTGSWNSGSSGTGSTGNQNPGSPRPGSTG | Fibrinogen alpha chain | Urine | 2736.1753 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10634 | VVDPKSKEEDKHLKFRISHELDS | Osteopontin | Urine | 2736.4296 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10635 | IPVKQADSGSSEEKQLYNKYPDAVA | Osteopontin | Urine | 2737.3666 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10636 | LHTVHFHGHSFQYKHRGVYSSDV | Ceruloplasmin | Urine | 2738.3413 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10637 | VAIDYINQNLPWGYKHTLNQIDE | Alpha-2-HS-glycoprotein | Urine | 2744.3252 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10638 | LKNGERIEKVEHSDLSFSKDWSF | Beta-2-microglobulin | Urine | 2751.4089 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10639 | DAHKSEVAHRFKDLGEENFKALVL | Serum albumin precursor | Urine | 2753.4445 | MALDI-TOF | Muscle-invasive bladder cancer | Upregulated in cancer vs normal | 21805675 |
| CancerPDF_ID10640 | TAQLDEELGGTPVQSRVVQGKEPAHL | Gelsolin | Urine | 2759.4407 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10641 | LSDLHAHKLRVDPVNFKLLSHCLL | Hemoglobin subunit alpha | Urine | 2768.5407 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10642 | IMYKVPLIRKKSLRRTLSERGLL | Pepsin A-3 | Urine | 2770.6958 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10643 | TPDVSSALDKLKEFGNTLEDKAREL | Apolipoprotein C-I | Urine | 2776.4278 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10644 | FGGKPMIIYKGGTSREGGQTAPASTRL | Gelsolin | Urine | 2780.4268 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10645 | EVDLLKNGERIEKVEHSDLSFSKD | Beta-2-microglobulin | Urine | 2787.4383 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10646 | AAHLPAEFTPAVHASLDKFLASVSTVL | Hemoglobin subunit alpha | Urine | 2792.4821 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10647 | VLSPADKTNVKAAWGKVGAHAGEYGAEA | Hemoglobin subunit alpha | Urine | 2797.431 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10648 | FKDSAHGFLKVPPRMDAKMYLGYE | Serotransferrin precursor | Urine | 2800.401 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10649 | WVHGLSKEQTSVSGAQKGRKQGGSQSS | Semenogelin-1 | Urine | 2814.4246 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10650 | IAFAQYLQQCPFEDHVKLVNEVTE | Serum albumin precursor | Urine | 2821.3731 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10651 | FQVRANSAGATRAVEVLPKAGALNSNDA | Gelsolin | Urine | 2827.4844 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10652 | DLLKNGERIEKVEHSDLSFSKDWS | Beta-2-microglobulin | Urine | 2832.4203 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10653 | ATLSELHCDKLHVDPENFRLLGNVL | Hemoglobin subunit beta | Urine | 2833.4663 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10654 | IPVKQADSGSSEEKQLYNKYPDAVAT | Osteopontin | Urine | 2838.4087 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10655 | LVVDPKSKEEDKHLKFRISHELDS | Osteopontin | Urine | 2849.4889 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10656 | PSRGKSSSYSKQFTSSTSYNRGDSTF | Fibrinogen alpha chain | Urine | 2862.3212 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10657 | IYTGLSKHVEDVPAFQALGSLNDLQF | Zinc-alpha-2-glycoprotein | Urine | 2862.4487 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10658 | LLKNGERIEKVEHSDLSFSKDWSF | Beta-2-microglobulin | Urine | 2864.4666 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10659 | VADTRDQADGSRASVDSGSSEEQGGSSRA | Polymeric immunoglobulin receptor | Urine | 2882.2712 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10660 | YLAPNNLKPVVAEFYGSKEDPQTFY | Serotransferrin precursor | Urine | 2890.4384 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10661 | VAWKADSSPVKAGVETTTPSKQSNNKY | Ig lambda chain C regions | Urine | 2893.4888 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10662 | IEVDLLKNGERIEKVEHSDLSFSKD | Beta-2-microglobulin | Urine | 2900.512 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10663 | LVTLAAHLPAEFTPAVHASLDKFLASVS | Hemoglobin subunit alpha | Urine | 2905.5638 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10664 | VLSPADKTNVKAAWGKVGAHAGEYGAEAL | Hemoglobin subunit alpha | Urine | 2910.5136 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10665 | VKHQTVPQNTGGKNPDPWAKNLNEKD | Serotransferrin precursor | Urine | 2915.4496 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10666 | APEAQVSVQPNFQQDKFLGRWFSAGL | Prostaglandin-H2 D-isomerase | Urine | 2920.478 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10667 | TPEEKSAVTALWGKVNVDEVGGEALGRL | Hemoglobin subunit beta | Urine | 2925.5337 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10668 | SALSDLHAHKLRVDPVNFKLLSHCLL | Hemoglobin subunit alpha | Urine | 2926.6099 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10669 | YMKHATKTAKDALSSVQESQVAQQARG | Apolipoprotein C-III | Urine | 2933.4811 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10670 | DAHKSEVAHRFKDLGEENFKALVLIA | Serum albumin precursor | Urine | 2937.554 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10671 | VHLTPEEKSAVTALWGKVNVDEVGGEAL | Hemoglobin subunit beta | Urine | 2948.5494 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10672 | AVADTRDQADGSRASVDSGSSEEQGGSSRA | Polymeric immunoglobulin receptor | Urine | 2953.2677 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10673 | SQFPHGQKGQHYSGQKGKQQTESKGSF | Semenogelin-1 | Urine | 2991.4467 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10674 | DGVSGGEGKGGSDGGGSHRKEGEEADAPGVIPG | CD99 antigen | Urine | 3022.3573 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10675 | LKNGERIEKVEHSDLSFSKDWSFYL | Beta-2-microglobulin | Urine | 3027.5298 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10676 | KVEIDTKSYWKALGISPFHEHAEVVF | Transthyretin | Urine | 3030.571 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10677 | LNNFYPREAKVQWKVDNALQSGNSQE | Ig kappa chain C region | Urine | 3035.4949 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10678 | GHRPLDKKREEAPSLRPAPPPISGGGYR | Fibrinogen beta chain | Urine | 3038.6362 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10679 | FVKHQTVPQNTGGKNPDPWAKNLNEKD | Serotransferrin precursor | Urine | 3062.5133 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10680 | VDLLKNGERIEKVEHSDLSFSKDWSF | Beta-2-microglobulin | Urine | 3078.5558 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10681 | KAVADTRDQADGSRASVDSGSSEEQGGSSRA | Polymeric immunoglobulin receptor | Urine | 3081.3834 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10682 | VTLAAHLPAEFTPAVHASLDKFLASVSTVL | Hemoglobin subunit alpha | Urine | 3105.6885 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10683 | VKDYFPEPVTVSWNSGALTSGVHTFPAVL | Ig gamma-1 chain C region | Urine | 3118.5887 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10684 | FSQFPHGQKGQHYSGQKGKQQTESKGSF | Semenogelin-1 | Urine | 3138.4767 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10685 | GTFATLSELHCDKLHVDPENFRLLGNVL | Hemoglobin subunit beta | Urine | 3138.5392 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10686 | IVITEHEVAQDDHLTQQYNEDRNPIST | Semenogelin-2 | Urine | 3165.4837 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10687 | IEVDLLKNGERIEKVEHSDLSFSKDWS | Beta-2-microglobulin | Urine | 3173.6186 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10688 | AKVQWKVDNALQSGNSQESVTEQDSKDST | Ig kappa chain C region | Urine | 3179.5088 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10689 | VAHVDDMPNALSALSDLHAHKLRVDPVNF | Hemoglobin subunit alpha | Urine | 3181.6283 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10690 | VLSPADKTNVKAAWGKVGAHAGEYGAEALER | Hemoglobin subunit alpha | Urine | 3195.6587 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10691 | VSETESRGSESGIFTNTKESSSHHPGIAEF | Fibrinogen alpha chain | Urine | 3207.4794 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10692 | VAWKADSSPVKAGVETTTPSKQSNNKYAASS | Ig lambda chain C regions | Urine | 3209.6254 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10693 | LTKKFSRHHGPTITAKLYGRAPQLRETL | Protein AMBP | Urine | 3219.8119 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10694 | EEVSGNVSPGTRREYHTEKLVTSKGDKEL | Fibrinogen alpha chain | Urine | 3245.6466 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10695 | LGRHSLFHPEDTGQVFQVSHSFPHPLYD | Prostate-specific antigen | Urine | 3247.5536 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10696 | AWKADSSPVKAGVETTTPSKQSNNKYAASSY | Ig lambda chain C regions | Urine | 3273.6064 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10697 | VHLTPEEKSAVTALWGKVNVDEVGGEALGRL | Hemoglobin subunit beta | Urine | 3274.7428 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10698 | DGVSGGEGKGGSDGGGSHRKEGEEADAPGVIPGIVG | CD99 antigen | Urine | 3291.569 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10699 | AEYHAKATEHLSTLSEKAKPALEDLRQGLL | Apolipoprotein A-I | Urine | 3319.7917 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10700 | IEVDLLKNGERIEKVEHSDLSFSKDWSF | Beta-2-microglobulin | Urine | 3320.6998 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10701 | VLSPADKTNVKAAWGKVGAHAGEYGAEALERM | Hemoglobin subunit alpha | Urine | 3326.7238 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10702 | PYQYPALTPEQKKELSDIAHRIVAPGKGIL | Fructose-bisphosphate aldolase A | Urine | 3332.8627 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10703 | EEKAVADTRDQADGSRASVDSGSSEEQGGSSRA | Polymeric immunoglobulin receptor | Urine | 3339.4925 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10704 | VDLLKNGERIEKVEHSDLSFSKDWSFYL | Beta-2-microglobulin | Urine | 3354.7279 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10705 | EDPQGDAAQKTDTSHHDQDHPTFNKITPNL | Alpha-1-antitrypsin | Urine | 3357.5577 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10706 | ADGVSGGEGKGGSDGGGSHRKEGEEADAPGVIPGIVG | CD99 antigen | Urine | 3362.5659 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10707 | VAWKADSSPVKAGVETTTPSKQSNNKYAASSY | Ig lambda chain C regions | Urine | 3372.6855 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10708 | VAHVDDMPNALSALSDLHAHKLRVDPVNFKL | Hemoglobin subunit alpha | Urine | 3422.8282 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10709 | EEKAVADTRDQADGSRASVDSGSSEEQGGSSRAL | Polymeric immunoglobulin receptor | Urine | 3452.5888 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10710 | VLSPADKTNVKAAWGKVGAHAGEYGAEALERMF | Hemoglobin subunit alpha | Urine | 3473.7931 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10711 | IEVDLLKNGERIEKVEHSDLSFSKDWSFY | Beta-2-microglobulin | Urine | 3483.7427 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10712 | VAWKADSSPVKAGVETTTPSKQSNNKYAASSYL | Ig lambda chain C regions | Urine | 3485.7858 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10713 | AHHFGKEFTPPVQAAYQKVVAGVANALAHKYH | Hemoglobin subunit beta | Urine | 3486.8198 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10714 | PTTKTYFPHFDLSHGSAQVKGHGKKVADALTNA | Hemoglobin subunit alpha | Urine | 3523.8388 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10715 | VAVHVFRKAADDTWEPFASGKTSESGELHGLTT | Transthyretin | Urine | 3543.7714 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10716 | EDPQGDAAQKTDTSHHDQDHPTFNKITPNLAE | Alpha-1-antitrypsin | Urine | 3557.6388 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10717 | GQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVL | Alpha-1-antitrypsin | Urine | 3578.0334 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10718 | AEYHAKATEHLSTLSEKAKPALEDLRQGLLPVL | Apolipoprotein A-I | Urine | 3629.0153 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10719 | VLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH | Hemoglobin subunit beta | Urine | 3698.9762 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10720 | EDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEF | Alpha-1-antitrypsin | Urine | 3704.7076 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10721 | FVEGIYKVEIDTKSYWKALGISPFHEHAEVVF | Transthyretin | Urine | 3738.9299 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10722 | EDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFA | Alpha-1-antitrypsin | Urine | 3775.7665 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10723 | STPDAVMGNPKVKAHGKKVLGAFSDGLAHLDNLKGTF | Hemoglobin subunit beta | Urine | 3821.0473 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10724 | AVHVFRKAADDTWEPFASGKTSESGELHGLTTEEE | Transthyretin | Urine | 3831.8486 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10725 | AEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLES | Apolipoprotein A-I | Urine | 3845.1017 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10726 | LSFPTTKTYFPHFDLSHGSAQVKGHGKKVADALTNA | Hemoglobin subunit alpha | Urine | 3871.0499 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10727 | VCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH | Hemoglobin subunit beta | Urine | 3901.0777 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10728 | VAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEE | Transthyretin | Urine | 3930.8524 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10729 | FLSFPTTKTYFPHFDLSHGSAQVKGHGKKVADALTNA | Hemoglobin subunit alpha | Urine | 4018.1173 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10730 | VAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEF | Transthyretin | Urine | 4078.0221 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10731 | GDLSTPDAVMGNPKVKAHGKKVLGAFSDGLAHLDNLKGTF | Hemoglobin subunit beta | Urine | 4106.2409 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10732 | FESFGDLSTPDAVMGNPKVKAHGKKVLGAFSDGLAHLDNLKGTF | Hemoglobin subunit beta | Urine | 4616.5053 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10733 | IAFAQY | Serum albumin precursor | Urine | 712.3755 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10734 | PSLAADF | Serum albumin precursor | Urine | 720.3502 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10735 | FHDDGF | Basement membrane-specific heparan sulfate proteoglycan core protein | Urine | 737.3013 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10736 | FKVSFL | Apolipoprotein A-I | Urine | 740.4406 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10737 | LAEGGGVR | Fibrinogen alpha chain | Urine | 758.4169 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10738 | TNDSVSF | Extracellular sulfatase Sulf-2 | Urine | 769.353 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10739 | FFKGEF | Hemopexin | Urine | 774.387 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10740 | FRVVAQG | Protein AMBP | Urine | 776.4269 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10741 | PSLGAVQI | Cyclic AMP-dependent transcription factor ATF-6 beta | Urine | 784.4338 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10742 | YGRAPQL | Protein AMBP | Urine | 804.424 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10743 | PPGFPPPP | Pre-mRNA 3'-end-processing factor FIP1 | Urine | 805.4618 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10744 | IAFAQYL | Serum albumin precursor | Urine | 825.4551 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10745 | VKHSTIF | Serotransferrin precursor | Urine | 831.4815 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10746 | DRITGKW | Alpha-1-acid glycoprotein 2 | Urine | 875.4532 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10747 | HTFTFPQ | MAX gene-associated protein | Urine | 877.453 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10748 | LNLGPITR | Uromodulin | Urine | 883.5165 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10749 | LVSLIGAMI | Putative sodium-coupled neutral amino acid transporter 9 | Urine | 916.5636 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10750 | ERMFLSF | Hemoglobin subunit alpha | Urine | 929.4521 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10751 | VCTPLGLAR | Protein LMBR1L | Urine | 929.4898 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10752 | DQSPPPPPP | Retinoblastoma-like protein 2 | Urine | 931.4513 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10753 | LKGEVSDAL | Interferon-induced protein with tetratricopeptide repeats 1-like protein | Urine | 931.4936 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10754 | FRLLGNVL | Hemoglobin subunit beta | Urine | 931.5745 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10755 | FHVDQVTT | Alpha-1-antitrypsin | Urine | 946.4686 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10756 | FVHEPLVD | Ribonuclease pancreatic | Urine | 955.4758 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10757 | RVREPVIS | Titin | Urine | 955.5656 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10758 | ESFKVSFL | Apolipoprotein A-I | Urine | 956.5084 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10759 | FSHVNIKL | Secreted and transmembrane protein 1 | Urine | 957.5455 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10760 | PRYPVGKF | Insulin-like growth factor II | Urine | 963.52 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10761 | WVFGGGTKL | Ig lambda chain V-VI region NIG-48 PE=1 SV=1 | Urine | 964.5108 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10762 | TVLTSKYR | Hemoglobin subunit alpha | Urine | 967.5594 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10763 | VLNLGPITR | Uromodulin | Urine | 982.6002 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10764 | KQTYLNQT | Low-density lipoprotein receptor-related protein 5 | Urine | 995.5532 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10765 | PVSGTLQGAGL | Large proline-rich protein BAT3 | Urine | 999.512 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10766 | DGRPGPPGPPG | Collagen alpha-1(I) chain | Urine | 1051.4902 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10767 | GPPGPPGLPGPQ | Collagen alpha-1(XI) chain | Urine | 1102.5625 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10768 | PGIGLPGPPGPK | Collagen alpha-5(IV) chain | Urine | 1102.6129 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10769 | RVGLPGPPGPPG | Collagen alpha-3(IX) chain | Urine | 1132.6275 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10770 | GPPGPPGPPGPPS | Collagen alpha-1(I) chain | Urine | 1142.5414 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10771 | GPPGEPGPPGPPG | Collagen alpha-2(V) chain | Urine | 1144.5172 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10772 | GPPGPPGPPGPPS | Collagen alpha-1(I) chain | Urine | 1158.5322 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10773 | GPPGPPGLPGPQG | Collagen alpha-1(XI) chain | Urine | 1159.561 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10774 | GVQGPPGPPGPPG | Collagen alpha-1(XVII) chain | Urine | 1161.5372 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10775 | GPVGPPGPPGPPG | Collagen alpha-1(I) chain | Urine | 1162.5267 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10776 | GPPGPPGSIGHPG | Collagen alpha-3(IX) chain | Urine | 1174.5463 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10777 | PGDRGEPGPPGP | Collagen alpha-1(I) chain | Urine | 1180.5198 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10778 | KRPPGFSPFR | Kininogen-1 | Urine | 1204.6522 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10779 | GQDGRPGPPGPPG | Collagen alpha-1(I) chain | Urine | 1236.5608 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10780 | APGDRGEPGPPGP | Collagen alpha-1(I) chain | Urine | 1251.5419 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10781 | SPGERGETGPPGP | Collagen alpha-1(III) chain | Urine | 1269.5617 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10782 | HPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 1276.6514 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10783 | GQDGRPGPPGPPGA | Collagen alpha-1(I) chain | Urine | 1307.6132 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10784 | APGDRGEPGPPGPA | Collagen alpha-1(I) chain | Urine | 1322.5948 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10785 | PPGPPGPPGPPGPPS | Collagen alpha-1(I) chain | Urine | 1352.6365 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10786 | PPGPPGPPGPPGPPA | EMI domain-containing protein 1 | Urine | 1368.6289 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10787 | APGDRGEPGPPGPAG | Collagen alpha-1(I) chain | Urine | 1379.6193 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10788 | GPPGPPGPPGHPGPQ | Collagen alpha-3(IV) chain | Urine | 1409.6345 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10789 | GPPGPPGPPGPPGPPS | Collagen alpha-1(I) chain | Urine | 1409.6706 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10790 | GPPGPPGPPGHPGPQ | Collagen alpha-3(IV) chain | Urine | 1425.6248 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10791 | GPPGPPGPPGPPGPPS | Collagen alpha-1(I) chain | Urine | 1425.6628 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10792 | DGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 1432.7003 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10793 | SPGSPGPDGKTGPPGP | Collagen alpha-1(I) chain | Urine | 1436.6463 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10794 | EPGKAGERGVPGPPG | Collagen alpha-1(I) chain | Urine | 1436.6914 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10795 | GLPGTGGPPGENGKPG | Collagen alpha-1(III) chain | Urine | 1439.6662 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10796 | GPPGPPGHPGPQGPP | Collagen alpha-3(IV) chain | Urine | 1441.6462 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10797 | GPMGPPGPPGPRGPAG | Collagen alpha-2(XI) chain precursor | Urine | 1446.6596 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10798 | DGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 1448.7088 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10799 | SPGSPGPDGKTGPPGP | Collagen alpha-1(I) chain | Urine | 1452.6738 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10800 | GAPGAAGNPGAPGHVGAP | Collagen alpha-1(XXII) chain | Urine | 1502.6774 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10801 | VGPPGPPGPPGPPGPPS | Collagen alpha-1(I) chain | Urine | 1508.7205 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10802 | VGPPGPPGPPGPPGPPS | Collagen alpha-1(I) chain | Urine | 1524.7269 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10803 | VGPPGPSGNAGPPGPPGP | Collagen alpha-1(I) chain | Urine | 1540.7191 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10804 | EDGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 1561.7434 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10805 | EDGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 1577.7497 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10806 | SPGSPGPDGKTGPPGPAG | Collagen alpha-1(I) chain | Urine | 1580.7286 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10807 | EDGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 1593.7148 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10808 | APGGKGDAGAPGERGPPG | Collagen alpha-1(III) chain | Urine | 1595.7246 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10809 | DGAPGKNGERGGPGGPGP | Collagen alpha-1(III) chain | Urine | 1624.724 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10810 | GEDGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 1634.7612 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10811 | SPGNIGPAGKEGPVGLPG | Collagen alpha-2(I) chain | Urine | 1635.8317 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10812 | GEDGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 1650.7464 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10813 | GLPGTGGPPGENGKPGEP | Collagen alpha-1(III) chain | Urine | 1681.7451 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10814 | DGPPGRDGQPGHKGER | Collagen alpha-2(I) chain | Urine | 1691.7914 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10815 | PPGEAGKPGEQGVPGDLG | Collagen alpha-1(I) chain | Urine | 1709.7991 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10816 | ESGRPGPPGPSGPRGQPG | Collagen alpha-1(III) chain | Urine | 1734.8147 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10817 | GPPGPPGKNGDDGEAGKPG | Collagen alpha-1(I) chain | Urine | 1735.789 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10818 | NDGAPGKNGERGGPGGPGP | Collagen alpha-1(III) chain | Urine | 1738.7711 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10819 | TGSPGSPGPDGKTGPPGPAG | Collagen alpha-1(I) chain | Urine | 1738.7988 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10820 | EPGSPGENGAPGQMGPRG | Collagen alpha-1(I) chain | Urine | 1742.7158 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10821 | DGPPGRDGQPGHKGERG | Collagen alpha-2(I) chain | Urine | 1748.8247 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10822 | GPPGPPGKNGDDGEAGKPG | Collagen alpha-1(I) chain | Urine | 1751.803 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10823 | GEKGPSGEAGTAGPPGTPGP | Collagen alpha-2(I) chain | Urine | 1752.7823 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10824 | DGEAGKPGRPGERGPPGP | Collagen alpha-1(I) chain | Urine | 1762.83 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10825 | GESGRPGPPGPSGPRGQPG | Collagen alpha-1(III) chain | Urine | 1791.8324 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10826 | GNDGAPGKNGERGGPGGPGP | Collagen alpha-1(III) chain | Urine | 1795.7895 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10827 | GEPGSPGENGAPGQMGPRG | Collagen alpha-1(I) chain | Urine | 1799.7353 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10828 | NDGPPGRDGQPGHKGER | Collagen alpha-2(I) chain | Urine | 1805.8075 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10829 | KLQGGTPQEPPNPRMK | Kinesin light chain 2 | Urine | 1809.9214 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10830 | SPGRDGSPGAKGDRGETGP | Collagen alpha-1(I) chain | Urine | 1829.8363 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10831 | GLPGTGGPPGENGKPGEPGP | Collagen alpha-1(III) chain | Urine | 1835.8664 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10832 | GLPGTGGPPGENGKPGEPGP | Collagen alpha-1(III) chain | Urine | 1835.8387 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10833 | APGAPGGKGDAGAPGERGPPG | Collagen alpha-1(III) chain | Urine | 1836.85 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10834 | APGGKGDAGAPGERGPPGLAG | Collagen alpha-1(III) chain | Urine | 1836.8793 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10835 | NDGPPGRDGQPGHKGERG | Collagen alpha-2(I) chain | Urine | 1862.8361 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10836 | DAGPAGPKGEPGSPGENGAPG | Collagen alpha-1(I) chain | Urine | 1866.8102 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10837 | DDGEAGKPGRPGERGPPGP | Collagen alpha-1(I) chain | Urine | 1877.8926 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10838 | GKAGEDGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 1890.9159 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10839 | GAPGAPGGKGDAGAPGERGPPG | Collagen alpha-1(III) chain | Urine | 1893.8628 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10840 | SPGRDGSPGAKGDRGETGPA | Collagen alpha-1(I) chain | Urine | 1900.8687 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10841 | GKAGEDGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 1906.9207 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10842 | GDDGEAGKPGRPGERGPPGP | Collagen alpha-1(I) chain | Urine | 1934.8887 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10843 | KDGESGRPGRPGERGLPGP | Collagen alpha-1(III) chain | Urine | 1934.9728 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10844 | EEGKRGPNGEAGSAGPPGPPG | Collagen alpha-2(I) chain | Urine | 1949.8923 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10845 | GDDGEAGKPGRPGERGPPGP | Collagen alpha-1(I) chain | Urine | 1950.8771 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10846 | KDGESGRPGRPGERGLPGP | Collagen alpha-1(III) chain | Urine | 1950.9633 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10847 | FDTASTGKTFPGFFSPML | Fibrinogen alpha chain | Urine | 1966.9275 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10848 | EPGGKGERGAPGEKGEGGPPG | Collagen alpha-1(III) chain | Urine | 1967.9029 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10849 | ILGGHLDAKGSFPWQAKM | Haptoglobin-related protein | Urine | 1972.0037 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10850 | DGESGRPGRPGERGLPGPPG | Collagen alpha-1(III) chain | Urine | 1992.9404 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10851 | DGESGRPGRPGERGLPGPPG | Collagen alpha-1(III) chain | Urine | 2008.9332 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10852 | EGSPGRDGSPGAKGDRGETGP | Collagen alpha-1(I) chain | Urine | 2015.9013 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10853 | GIPGEKGPAGERGAPGPAGPRG | Collagen alpha-1(III) chain | Urine | 2017.0132 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10854 | GEPGGKGERGAPGEKGEGGPPG | Collagen alpha-1(III) chain | Urine | 2024.9347 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10855 | SEGSPGHPGQPGPPGPPGAPGP | Collagen alpha-1(III) chain | Urine | 2026.856 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10856 | PPGEAGKPGEQGVPGDLGAPGP | Collagen alpha-1(I) chain | Urine | 2047.9459 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10857 | NGDDGEAGKPGRPGERGPPGP | Collagen alpha-1(I) chain | Urine | 2048.9342 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10858 | DAGAPGAPGGKGDAGAPGERGPPG | Collagen alpha-1(III) chain | Urine | 2063.9189 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10859 | NGDDGEAGKPGRPGERGPPGP | Collagen alpha-1(I) chain | Urine | 2064.9331 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10860 | DAGAPGAPGGKGDAGAPGERGPPG | Collagen alpha-1(III) chain | Urine | 2079.9266 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10861 | DGPPGRDGQPGHKGERGYPG | Collagen alpha-2(I) chain | Urine | 2081.9399 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10862 | EGSPGRDGSPGAKGDRGETGPA | Collagen alpha-1(I) chain | Urine | 2086.9368 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10863 | GAPGNDGAKGDAGAPGAPGSQGAPG | Collagen alpha-1(I) chain | Urine | 2097.9094 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10864 | PPGKAGEDGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 2101.0124 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10865 | GPPGEAGKPGEQGVPGDLGAPGP | Collagen alpha-1(I) chain | Urine | 2104.972 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10866 | PPGKAGEDGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 2117.0065 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10867 | DGQPGAKGEPGDAGAKGDAGPPGP | Collagen alpha-1(I) chain | Urine | 2118.9623 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10868 | DGKTGPPGPAGQDGRPGPPGPPG | Collagen alpha-1(I) chain | Urine | 2129.9647 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10869 | NGIPGEKGPAGERGAPGPAGPRG | Collagen alpha-1(III) chain | Urine | 2131.0582 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10870 | GRDGNPGNDGPPGRDGQPGHK | Collagen alpha-2(I) chain | Urine | 2132.9349 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10871 | DGQPGAKGEPGDAGAKGDAGPPGP | Collagen alpha-1(I) chain | Urine | 2134.9677 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10872 | GDAGAPGAPGGKGDAGAPGERGPPG | Collagen alpha-1(III) chain | Urine | 2136.9478 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10873 | NGEPGGKGERGAPGEKGEGGPPG | Collagen alpha-1(III) chain | Urine | 2138.9753 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10874 | NGIPGEKGPAGERGAPGPAGPRG | Collagen alpha-1(III) chain | Urine | 2147.0405 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10875 | DGQPGAKGEPGDAGAKGDAGPPGP | Collagen alpha-1(I) chain | Urine | 2150.9347 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10876 | PGDAGAKGDAGPPGPAGPAGPPGPIG | Collagen alpha-1(I) chain | Urine | 2151.0303 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10877 | NGEPGGKGERGAPGEKGEGGPPG | Collagen alpha-1(III) chain | Urine | 2154.9697 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10878 | NSGEPGAPGSKGDTGAKGEPGPVG | Collagen alpha-1(I) chain | Urine | 2154.9723 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10879 | AEGSPGRDGSPGAKGDRGETGPA | Collagen alpha-1(I) chain | Urine | 2157.9725 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10880 | GPPGKAGEDGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 2158.0406 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10881 | AGPPGEAGKPGEQGVPGDLGAPGP | Collagen alpha-1(I) chain | Urine | 2160.0021 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10882 | SDGQPGPPGPPGTAGFPGSPGAKG | Collagen alpha-1(III) chain | Urine | 2169.9663 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10883 | NSGEPGAPGSKGDTGAKGEPGPVG | Collagen alpha-1(I) chain | Urine | 2170.9735 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10884 | PGAAEGGAARTAGGMAVAGTATGPR | Protein FAM71B | Urine | 2171.0578 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10885 | GPPGKAGEDGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 2174.0264 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10886 | AGPPGEAGKPGEQGVPGDLGAPGP | Collagen alpha-1(I) chain | Urine | 2176.0067 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10887 | ADGQPGAKGEPGDAGAKGDAGPPGP | Collagen alpha-1(I) chain | Urine | 2189.9958 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10888 | NDGAPGKNGERGGPGGPGPQGPPG | Collagen alpha-1(III) chain | Urine | 2190.9709 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10889 | NGDDGEAGKPGRPGERGPPGPQ | Collagen alpha-1(I) chain | Urine | 2192.9891 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10890 | NDGPPGRDGQPGHKGERGYPG | Collagen alpha-2(I) chain | Urine | 2195.9632 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10891 | ADGQPGAKGEPGDAGAKGDAGPPGP | Collagen alpha-1(I) chain | Urine | 2206.0017 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10892 | EAIPMSIPPEVKFNKPFVF | Alpha-1-antitrypsin | Urine | 2206.151 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10893 | NGAPGNDGAKGDAGAPGAPGSQGAPG | Collagen alpha-1(I) chain | Urine | 2211.9426 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10894 | ADGQPGAKGEPGDAGAKGDAGPPGP | Collagen alpha-1(I) chain | Urine | 2221.9847 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10895 | GNSGEPGAPGSKGDTGAKGEPGPVG | Collagen alpha-1(I) chain | Urine | 2227.9964 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10896 | AGPPGKAGEDGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 2229.0674 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10897 | NGDDGEAGKPGRPGERGPPGPQG | Collagen alpha-1(I) chain | Urine | 2234.0037 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10898 | GRTGDAGPVGPPGPPGPPGPPGPPS | Collagen alpha-1(I) chain | Urine | 2236.054 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10899 | AGPPGKAGEDGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 2245.0637 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10900 | GADGQPGAKGEPGDAGAKGDAGPPGP | Collagen alpha-1(I) chain | Urine | 2247.0131 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10901 | DGNPGNDGPPGRDGQPGHKGER | Collagen alpha-2(I) chain | Urine | 2261.9931 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10902 | GADGQPGAKGEPGDAGAKGDAGPPGP | Collagen alpha-1(I) chain | Urine | 2263.014 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10903 | KGDAGAPGAPGGKGDAGAPGERGPPG | Collagen alpha-1(III) chain | Urine | 2265.0274 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10904 | QNGEPGGKGERGAPGEKGEGGPPG | Collagen alpha-1(III) chain | Urine | 2267.0218 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10905 | ADGQPGAKGEPGDAGAKGDAGPPGPA | Collagen alpha-1(I) chain | Urine | 2277.0228 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10906 | GADGQPGAKGEPGDAGAKGDAGPPGP | Collagen alpha-1(I) chain | Urine | 2279.0018 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10907 | ANGAPGNDGAKGDAGAPGAPGSQGAPG | Collagen alpha-1(I) chain | Urine | 2282.9953 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10908 | QNGEPGGKGERGAPGEKGEGGPPG | Collagen alpha-1(III) chain | Urine | 2283.0055 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10909 | ADGQPGAKGEPGDAGAKGDAGPPGPA | Collagen alpha-1(I) chain | Urine | 2293.0049 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10910 | RTGDAGPVGPPGPPGPPGPPGPPSAG | Collagen alpha-1(I) chain | Urine | 2307.0867 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10911 | GRDGNPGNDGPPGRDGQPGHKGE | Collagen alpha-2(I) chain | Urine | 2319.0397 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10912 | LEAIPMSIPPEVKFNKPFVF | Alpha-1-antitrypsin | Urine | 2319.236 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10913 | AGPPGEAGKPGEQGVPGDLGAPGPSG | Collagen alpha-1(I) chain | Urine | 2320.0655 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10914 | GQNGEPGGKGERGAPGEKGEGGPPG | Collagen alpha-1(III) chain | Urine | 2324.0398 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10915 | EAGRDGNPGNDGPPGRDGQPGHK | Collagen alpha-2(I) chain | Urine | 2333.0224 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10916 | GADGQPGAKGEPGDAGAKGDAGPPGPA | Collagen alpha-1(I) chain | Urine | 2334.0496 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10917 | GANGAPGNDGAKGDAGAPGAPGSQGAPG | Collagen alpha-1(I) chain | Urine | 2340.023 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10918 | GADGQPGAKGEPGDAGAKGDAGPPGPA | Collagen alpha-1(I) chain | Urine | 2350.0263 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10919 | KGNSGEPGAPGSKGDTGAKGEPGPVG | Collagen alpha-1(I) chain | Urine | 2356.0992 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10920 | KNGDDGEAGKPGRPGERGPPGPQG | Collagen alpha-1(I) chain | Urine | 2362.0988 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10921 | ERGSEGSPGHPGQPGPPGPPGAPGP | Collagen alpha-1(III) chain | Urine | 2369.0258 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10922 | GKNGDDGEAGKPGRPGERGPPGPQ | Collagen alpha-1(I) chain | Urine | 2378.0898 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10923 | GPAGPPGKAGEDGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 2399.1292 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10924 | LDGAKGDAGPAGPKGEPGSPGENGAPG | Collagen alpha-1(I) chain | Urine | 2408.0796 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10925 | RGGAGPPGPEGGKGAAGPPGPPGAAGTPG | Collagen alpha-1(III) chain | Urine | 2413.113 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10926 | GPAGPPGKAGEDGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 2415.1359 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10927 | LDGAKGDAGPAGPKGEPGSPGENGAPG | Collagen alpha-1(I) chain | Urine | 2424.0752 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10928 | ADGQPGAKGEPGDAGAKGDAGPPGPAGP | Collagen alpha-1(I) chain | Urine | 2431.0989 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10929 | PPGKNGDDGEAGKPGRPGERGPPGP | Collagen alpha-1(I) chain | Urine | 2444.1487 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10930 | TGPIGPPGPAGAPGDKGESGPSGPAGPTG | Collagen alpha-1(I) chain | Urine | 2472.148 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10931 | GRDGNPGNDGPPGRDGQPGHKGER | Collagen alpha-2(I) chain | Urine | 2475.1004 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10932 | PPGESGREGAPGAEGSPGRDGSPGAKG | Collagen alpha-1(I) chain | Urine | 2482.1157 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10933 | GADGQPGAKGEPGDAGAKGDAGPPGPAGP | Collagen alpha-1(I) chain | Urine | 2488.1186 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10934 | PPGADGQPGAKGEPGDAGAKGDAGPPGP | Collagen alpha-1(I) chain | Urine | 2489.1067 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10935 | RGANGAPGNDGAKGDAGAPGAPGSQGAPG | Collagen alpha-1(I) chain | Urine | 2496.0978 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10936 | PPGESGREGAPGAEGSPGRDGSPGAKG | Collagen alpha-1(I) chain | Urine | 2498.1007 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10937 | GPPGKNGDDGEAGKPGRPGERGPPGP | Collagen alpha-1(I) chain | Urine | 2501.1697 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10938 | GADGQPGAKGEPGDAGAKGDAGPPGPAGP | Collagen alpha-1(I) chain | Urine | 2504.1284 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10939 | APGQNGEPGGKGERGAPGEKGEGGPPG | Collagen alpha-1(III) chain | Urine | 2508.1252 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10940 | GPPGKNGDDGEAGKPGRPGERGPPGP | Collagen alpha-1(I) chain | Urine | 2517.1546 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10941 | EAGRDGNPGNDGPPGRDGQPGHKGE | Collagen alpha-2(I) chain | Urine | 2519.0939 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10942 | APGQNGEPGGKGERGAPGEKGEGGPPG | Collagen alpha-1(III) chain | Urine | 2524.1102 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10943 | LRGGAGPPGPEGGKGAAGPPGPPGAAGTPG | Collagen alpha-1(III) chain | Urine | 2526.2258 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10944 | GRDGNPGNDGPPGRDGQPGHKGERG | Collagen alpha-2(I) chain | Urine | 2532.1321 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10945 | LRGGAGPPGPEGGKGAAGPPGPPGAAGTPG | Collagen alpha-1(III) chain | Urine | 2542.2087 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10946 | GPPGADGQPGAKGEPGDAGAKGDAGPPGP | Collagen alpha-1(I) chain | Urine | 2546.1376 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10947 | GAPGQNGEPGGKGERGAPGEKGEGGPPG | Collagen alpha-1(III) chain | Urine | 2549.1613 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10948 | KNGETGPQGPPGPTGPGGDKGDTGPPGP | Collagen alpha-1(III) chain | Urine | 2558.1569 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10949 | PPGADGQPGAKGEPGDAGAKGDAGPPGPA | Collagen alpha-1(I) chain | Urine | 2560.1518 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10950 | GAPGQNGEPGGKGERGAPGEKGEGGPPG | Collagen alpha-1(III) chain | Urine | 2565.1498 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10951 | AGPPGAPGAPGAPGPVGPAGKSGDRGETGP | Collagen alpha-1(I) chain | Urine | 2568.239 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10952 | GAPGQNGEPGGKGERGAPGEKGEGGPPG | Collagen alpha-1(III) chain | Urine | 2581.145 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10953 | AGPPGAPGAPGAPGPVGPAGKSGDRGETGP | Collagen alpha-1(I) chain | Urine | 2584.272 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10954 | PPGKNGDDGEAGKPGRPGERGPPGPQ | Collagen alpha-1(I) chain | Urine | 2588.208 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10955 | AGPPGAPGAPGAPGPVGPAGKSGDRGETGP | Collagen alpha-1(I) chain | Urine | 2600.223 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10956 | GPPGADGQPGAKGEPGDAGAKGDAGPPGPA | Collagen alpha-1(I) chain | Urine | 2617.1733 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10957 | ARGPAGPPGKAGEDGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 2626.2534 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10958 | QGPPGPSGEEGKRGPNGEAGSAGPPGPPG | Collagen alpha-2(I) chain | Urine | 2627.1788 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10959 | GLPGPAGPPGEAGKPGEQGVPGDLGAPGP | Collagen alpha-1(I) chain | Urine | 2629.2181 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10960 | KEGGKGPRGETGPAGRPGEVGPPGPPGP | Collagen alpha-1(I) chain | Urine | 2640.2889 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10961 | KEGGKGPRGETGPAGRPGEVGPPGPPGP | Collagen alpha-1(I) chain | Urine | 2640.2997 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10962 | ARGPAGPPGKAGEDGHPGKPGRPGERG | Collagen alpha-2(I) chain | Urine | 2642.2717 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10963 | QGPPGPSGEEGKRGPNGEAGSAGPPGPPG | Collagen alpha-2(I) chain | Urine | 2643.1969 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10964 | GPPGKNGDDGEAGKPGRPGERGPPGPQ | Collagen alpha-1(I) chain | Urine | 2645.2344 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10965 | NRGERGSEGSPGHPGQPGPPGPPGAPGP | Collagen alpha-1(III) chain | Urine | 2648.1994 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10966 | AVGPPGFAGEKGPSGEAGTAGPPGTPGPQG | Collagen alpha-2(I) chain | Urine | 2650.2165 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10967 | ERGEAGIPGVPGAKGEDGKDGSPGEPGA | Collagen alpha-1(III) chain | Urine | 2655.2113 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10968 | NRGERGSEGSPGHPGQPGPPGPPGAPGP | Collagen alpha-1(III) chain | Urine | 2664.2119 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10969 | EAGRDGNPGNDGPPGRDGQPGHKGER | Collagen alpha-2(I) chain | Urine | 2675.1926 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10970 | NRGERGSEGSPGHPGQPGPPGPPGAPGP | Collagen alpha-1(III) chain | Urine | 2680.1757 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10971 | KDGEAGAQGPPGPAGPAGERGEQGPAGSPG | Collagen alpha-1(I) chain | Urine | 2688.2119 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10972 | NRGERGSEGSPGHPGQPGPPGPPGAPGP | Collagen alpha-1(III) chain | Urine | 2696.2304 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10973 | PPGADGQPGAKGEPGDAGAKGDAGPPGPAGP | Collagen alpha-1(I) chain | Urine | 2714.2168 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10974 | KNGETGPQGPPGPTGPGGDKGDTGPPGPQG | Collagen alpha-1(III) chain | Urine | 2727.2526 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10975 | EAGRDGNPGNDGPPGRDGQPGHKGERG | Collagen alpha-2(I) chain | Urine | 2732.2053 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10976 | NDGARGSDGQPGPPGPPGTAGFPGSPGAKG | Collagen alpha-1(III) chain | Urine | 2740.2117 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10977 | KNGETGPQGPPGPTGPGGDKGDTGPPGPQG | Collagen alpha-1(III) chain | Urine | 2743.2447 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10978 | ERGSPGPAGPKGSPGEAGRPGEAGLPGAKG | Collagen alpha-1(I) chain | Urine | 2762.3302 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10979 | KEGGKGPRGETGPAGRPGEVGPPGPPGPAG | Collagen alpha-1(I) chain | Urine | 2768.3665 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10980 | GPPGADGQPGAKGEPGDAGAKGDAGPPGPAGP | Collagen alpha-1(I) chain | Urine | 2771.2373 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10981 | ERGSPGPAGPKGSPGEAGRPGEAGLPGAKG | Collagen alpha-1(I) chain | Urine | 2778.3258 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10982 | ERGEAGIPGVPGAKGEDGKDGSPGEPGANG | Collagen alpha-1(III) chain | Urine | 2810.2794 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10983 | LRGGAGPPGPEGGKGAAGPPGPPGAAGTPGLQG | Collagen alpha-1(III) chain | Urine | 2824.4013 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10984 | ERGEAGIPGVPGAKGEDGKDGSPGEPGANG | Collagen alpha-1(III) chain | Urine | 2826.275 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10985 | PPGPPGKNGDDGEAGKPGRPGERGPPGPQ | Collagen alpha-1(I) chain | Urine | 2855.2918 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10986 | GRDGNPGNDGPPGRDGQPGHKGERGYPG | Collagen alpha-2(I) chain | Urine | 2865.2657 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10987 | GRDGNPGNDGPPGRDGQPGHKGERGYPG | Collagen alpha-2(I) chain | Urine | 2881.2582 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10988 | VNGAPGEAGRDGNPGNDGPPGRDGQPGHKG | Collagen alpha-2(I) chain | Urine | 2901.2748 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10989 | GPPGPPGKNGDDGEAGKPGRPGERGPPGPQ | Collagen alpha-1(I) chain | Urine | 2912.3455 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10990 | GMPGSPGGPGSDGKPGPPGSQGESGRPGPPGP | Collagen alpha-1(III) chain | Urine | 2921.2391 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10991 | RGPPGPPGKNGDDGEAGKPGRPGERGPPGP | Collagen alpha-1(I) chain | Urine | 2924.4042 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10992 | VLSPADKTNVKAAWGKVGAHAGEYGAEAL | Hemoglobin subunit alpha | Urine | 2926.5099 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10993 | ESGREGAPGAEGSPGRDGSPGAKGDRGETGP | Collagen alpha-1(I) chain | Urine | 2927.3115 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10994 | ESGREGAPGAEGSPGRDGSPGAKGDRGETGP | Collagen alpha-1(I) chain | Urine | 2943.2682 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10995 | NVGAPGAKGARGSAGPPGATGFPGAAGRVGPPGP | Collagen alpha-1(I) chain | Urine | 2974.4763 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10996 | GESGREGAPGAEGSPGRDGSPGAKGDRGETGP | Collagen alpha-1(I) chain | Urine | 2984.3374 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10997 | GESGREGAPGAEGSPGRDGSPGAKGDRGETGP | Collagen alpha-1(I) chain | Urine | 3000.2871 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10998 | ESGREGAPGAEGSPGRDGSPGAKGDRGETGPA | Collagen alpha-1(I) chain | Urine | 3014.3608 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10999 | ARGNDGARGSDGQPGPPGPPGTAGFPGSPGAKG | Collagen alpha-1(III) chain | Urine | 3024.3801 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11000 | QNGEPGGKGERGAPGEKGEGGPPGVAGPPGGSGP | Collagen alpha-1(III) chain | Urine | 3059.3961 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11001 | EAGRDGNPGNDGPPGRDGQPGHKGERGYPG | Collagen alpha-2(I) chain | Urine | 3065.3383 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11002 | QNGEPGGKGERGAPGEKGEGGPPGVAGPPGGSGP | Collagen alpha-1(III) chain | Urine | 3075.3859 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11003 | VAHVDDMPNALSALSDLHAHKLRVDPVNF | Hemoglobin subunit alpha | Urine | 3197.6092 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11004 | PPGESGREGAPGAEGSPGRDGSPGAKGDRGETGP | Collagen alpha-1(I) chain | Urine | 3210.4694 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11005 | PPGESGREGAPGAEGSPGRDGSPGAKGDRGETGP | Collagen alpha-1(I) chain | Urine | 3226.3807 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11006 | ENGKPGEPGPKGDAGAPGAPGGKGDAGAPGERGPPG | Collagen alpha-1(III) chain | Urine | 3243.4948 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11007 | RTGEVGAVGPPGFAGEKGPSGEAGTAGPPGTPGPQG | Collagen alpha-2(I) chain | Urine | 3249.5368 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11008 | ENGKPGEPGPKGDAGAPGAPGGKGDAGAPGERGPPG | Collagen alpha-1(III) chain | Urine | 3259.5101 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11009 | RTGEVGAVGPPGFAGEKGPSGEAGTAGPPGTPGPQG | Collagen alpha-2(I) chain | Urine | 3265.5277 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11010 | AAGEPGKAGERGVPGPPGAVGPAGKDGEAGAQGPPGP | Collagen alpha-1(I) chain | Urine | 3265.5702 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11011 | GPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGP | Collagen alpha-1(I) chain | Urine | 3267.4917 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11012 | NTGAPGSPGVSGPKGDAGQPGEKGSPGAQGPPGAPGP | Collagen alpha-1(III) chain | Urine | 3272.4927 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11013 | ENGKPGEPGPKGDAGAPGAPGGKGDAGAPGERGPPG | Collagen alpha-1(III) chain | Urine | 3275.4979 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11014 | PPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPA | Collagen alpha-1(I) chain | Urine | 3281.4884 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11015 | NTGAPGSPGVSGPKGDAGQPGEKGSPGAQGPPGAPGP | Collagen alpha-1(III) chain | Urine | 3288.4952 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11016 | NTGAPGSPGVSGPKGDAGQPGEKGSPGAQGPPGAPGP | Collagen alpha-1(III) chain | Urine | 3304.4968 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11017 | ERGEAGIPGVPGAKGEDGKDGSPGEPGANGLPGAAG | Collagen alpha-1(III) chain | Urine | 3308.504 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11018 | GPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPA | Collagen alpha-1(I) chain | Urine | 3338.5287 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11019 | GAPGQNGEPGGKGERGAPGEKGEGGPPGVAGPPGGSGP | Collagen alpha-1(III) chain | Urine | 3373.5214 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11020 | PPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPPGPIG | Collagen alpha-1(I) chain | Urine | 3376.5722 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11021 | VKGERGSPGGPGAAGFPGARGLPGPPGSNGNPGPPGP | Collagen alpha-1(III) chain | Urine | 3386.609 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11022 | ARGNDGARGSDGQPGPPGPPGTAGFPGSPGAKGEVGP | Collagen alpha-1(III) chain | Urine | 3406.5192 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11023 | VAHVDDMPNALSALSDLHAHKLRVDPVNFKL | Hemoglobin subunit alpha | Urine | 3438.8067 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11024 | NTGAPGSPGVSGPKGDAGQPGEKGSPGAQGPPGAPGPLG | Collagen alpha-1(III) chain | Urine | 3458.629 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11025 | NTGAPGSPGVSGPKGDAGQPGEKGSPGAQGPPGAPGPLG | Collagen alpha-1(III) chain | Urine | 3474.6119 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11026 | QNGEPGGKGERGAPGEKGEGGPPGVAGPPGGSGPAGPPGPQG | Collagen alpha-1(III) chain | Urine | 3736.6961 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11027 | NDGARGSDGQPGPPGPPGTAGFPGSPGAKGEVGPAGSPGSNGAPG | Collagen alpha-1(III) chain | Urine | 4022.7806 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11028 | SKGESGNKGEPGSAGPQGPPGPSGEEGKRGPNGEAGSAGPPGPPG | Collagen alpha-2(I) chain | Urine | 4066.8417 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11029 | SKGESGNKGEPGSAGPQGPPGPSGEEGKRGPNGEAGSAGPPGPPG | Collagen alpha-2(I) chain | Urine | 4114.8649 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11030 | ARGNDGATGAAGPPGPTGPAGPPGFPGAVGAKGEAGPQGPRGSEGPQG | Collagen alpha-1(I) chain | Urine | 4253.0061 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11031 | ARGNDGARGSDGQPGPPGPPGTAGFPGSPGAKGEVGPAGSPGSNGAPG | Collagen alpha-1(III) chain | Urine | 4306.9377 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11032 | LQGLPGTGGPPGENGKPGEPGPKGDAGAPGAPGGKGDAGAPGERGPPG | Collagen alpha-1(III) chain | Urine | 4323.0038 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |